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Heat Killed Mycobacterium Vaccination Suppressed Severe Dermatitis in
AD-Model Mouse Converting Th2 into Th1 Cytokine Pro¢le
T. Murakami, K.-i. Yamanaka, K. Yamanishi, and H. Mizutani
Department of Dermatology, Mie University, Faculty of MedicineTsu, Mie, Japan
Atopic dermatitis (AD) is a chronic in£ammatory disease based on T-helper cell (Th2) immune re-
sponses. The recent increase of the prevalence of AD has been suggested caused by a cleaner environ-
ment and fewer childhood mycobacterium infections.While topical and systemic immunosuppressive
medicine improved AD clinically, the reconstitution of the balance between Th2 and Th1 is an ideal
therapy for AD. Here we report signi¢cant e¡ect of a heat killed BCG vaccine in an AD model mouse
Caspase-1Tg (CASP1Tg). CASP1Tg express severe itching dermatitis with elevated plasma histamine,
IgE, IL-18, cutaneous mastocytes counts and lesional IL-4, IL-5 and IL-10 mRNA expression. After
weekly vaccination with 100 micrograms of heat killed BCG for 10 weeks, the cutaneous manifesta-
tions were signi¢cantly suppressed. According to improvement of the cutaneous manifestation, levels
of plasma histamine, IgE, and IL-18 were suppressed. The lesional IL-4, IL-5 and IL-10 expression
were downregulated, but IFN-g mRNAwas augmented. No relapse of the cutaneous nor laboratory
manifestations of AD was observed over 6 months following-up after discontinuance of this therapy.
No particular side e¡ects was observed in this study. Thus, the heat-killed BCG vaccination is a po-
tential therapy for AD, performing an essential role in AD therapy with restoring the balance of Th1/
Th2 cells.
IL-18 Transgenic Mice Spontaneously Develop Atopic Dermatitis-Like Skin
Lesions
H. Mizutani,T. Murakami, and H. Konishi
Department of Dermatology, Mie University, Faculty of Medicine,Tsu, Japan
We have reported skin-speci¢c caspase-1 transgenic mice (CASP1Tg) as a model for atopic dermatitis
previously. CASP1, expressed in the epidermis has three functions. It activates the endogenous proIL-1
beta and proIL-18 and secretes as the active forms, and induced apoptosis to the epidermal keratino-
cytes. To con¢rm function of IL-18 in vivo, we have established K14 promoter driven mature IL-18
transgenic mice (IL-18Tg). IL-18Tg secreted biologically active IL-18 from the epidermis in a speci¢c
pathogen free condition. At 24 weeks-old, IL-18Tg spontaneously developed itching and recalcitrant
dermatitis combined with overproduced IgE and Th2 cytokines. The erythematous lesions were with
licheni¢cation and ¢ne scales. Histologically, the epidermis showed acanthosis with marked dermal
mastocytosis. IL-18Tg takes long time to express the phenotype compared with that of CASP1Tg (8
weeks). To know the di¡erence, we crossed CASP1Tg and IL-1 alpha/beta knockout mouse. IL-1s-/-
CASP1Tg developed dermatitis at 24 weeks. IL-18 may be critically involved in an AD-like dermatitis
and IL-1s enhance development of the dermatitis.
Cutaneous Route Sensitization with Natural Rubber Latex Elicits in Mice a Strong
Th2 Type Systemic Immune Response and Th2 Dominated Lung In£ammation
After Airway Latex Challenge
H. Alenius, M. Lehto, R. Haapakoski, K. Turjanmaa#,T. Palosuo&, and T. Reunala#
Finnish Institute of Occupational Health, Helsinki; #Department of Dermatology, University and University
Hospital ofTampere,Tampere; &National Public Health Institute, Helsinki, Finland
Atopy and hand dermatitis are important risk factors for the development of natural rubber latex
(NRL) allergy.We recently reported that cutaneous route sensitization with NRL induces Th2-domi-
nated dermal in£ammation in a murine model. Here we investigated the signi¢cance of di¡erent sen-
sitization routes in the production of IgE antibodies and in the development of airway
hyperresponsiveness in mice. Intracutaneous (IC) and intraperitoneal (IP) but not intranasal (IN) route
sensitization with NRL induced a striking increase in the total and speci¢c IgE levels. Both IC and IP
sensitization with NRL produced also a signi¢cant in£ux of eosinophils and lymphocytes to the
lungs after airway NRL challenge. In¢ltration of in£ammatory cells was associated with induction
of Th2 type cytokine (IL-4, IL-5 and IL-13) and chemokine (CCL3/MIP1-alpha and CCL11/eotax-
in-1) mRNA levels in the lungs. Only marginal induction of these cytokines and chemokines was
found after IN sensitization with NRL, whereas moderate or strong induction was seen after IP or
IC sensitization, respectively. Finally, signi¢cant increase in the bronchial reactivity to inhaled metha-
choline was found after IC and IP sensitization with NRL but not after IN sensitization. These results
demonstrate that cutaneous route sensitization induces the production of IgE antibodies and elicits
also Th2-dominated airway in£ammation and airway hyper-responsiveness after NRL challenge in
mice. Cutaneous route sensitization to proteins eluting from NRL gloves may therefore play an im-
portant role in the production of NRL-speci¢c IgE antibodies but also in the development of airway
hyperresponsiveness to latex.
Up Regulation of Human Manganese Superoxide Dismutase ^ a Stress-Inducible
Enzyme ^ Can Elicit Autoimmune IgE- and T Cell-Mediated Eczematous Reac-
tions in Atopic Dermatitis
P. Schmid-Grendelmeier1,2, S. Flˇckiger3, R. Disch4, K. Blaser2, B.Wˇthrich1, and R. Crameri2
1Allergy Unit, Dept. of Dermatology, University of Zˇrich, Z rˇich, 2Swiss Institute forAllergy &Asthma Research
(SIAF) Davos; 3BiovisioN Schweiz AG, Davos; and 4Alexanderhausklinik, CH-7270 Davos, all Switzerland
Although the pathogenesis of atopic dermatitis is still not fully understood, autoreactivity of AD pa-
tients to human proteins suggests self antigens as decisive factor driving disease exacerbation. Human
manganese superoxide dismutase (hMnSOD)  a stress-inducible enzyme  is known to elicit auto-
immune reactions in chronic allergic diseases. Using structurally di¡erent, recombinantly produced
MnSOD of fungal and human origin, various in vitro and in vivo investigations in patients with atopic
dermatitis, other in£ammatory skin diseases and healthy controls were performed. In the current
study we found hMnSOD-speci¢c immunoglobulin E (IgE) antibodies determined by ELISA in sera
from 29 out of 67 AD patients (36%), but not in sera of other patients or healthy controls - correlating
signi¢cantly with disease activity (R¼ 0.783, po0.0001). In sensitised patients, rhMnSOD induced T
cell proliferation and showed in vivo reactivity, demonstrated by positive skin prick- and atopy patch
tests. Expression of MnSOD in lesional skin of AD was stage-dependant and upregulated in atopy
patch tests in comparison to the levels detected in non-AD skin diseases or healthy skin, as shown by
immunohistochemistry. Primary sensitization to hMnSOD might be induced by cross-reacting fungal
MnSOD as all patients showed positive skin reactions to fungal extracts. Moreover, rhMnSOD was
able to compete for IgE binding to fungal extracts in RAST inhibition experiments. These data pro-
vide strong evidence for an important role of hMnSOD autoreactivity as a disease-exacerbating,
stress-dependantly upregulated factor in a relevant subset of AD patients.
Atopic Dermatitis and T Cells
K. Thestrup-Pedersen
Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark
T lymphocytes are the predominant cell of the cutaneous in£ammation creating atopic eczema. They
are activated expressing various activation markers.We have demonstrated that an adult with 30% of
the skin a¡ected with eczema have double the number of T lymphocytes in the skin than in the
peripheral blood. We have also observed a signi¢cant reduction of the telomere length of both
CD4þ and CD8þ T cells, both in blood and among skin-homing T lymphocytes. Recent studies
have revealed that the T cell receptor excision circles (TREC) can be both augmented, but also re-
duced, in atopic dermatitis. All results point to an increased turn-over in the peripheral T lymphocyte
immune system.We have therefore suggested that atopic dermatitis is associated with or maybe caused
by a skewed establishment of the peripheral T lymphocyte system ^ possibly due to an emission of
faulty selected T lymphocytes in the thymus. Once the children down-regulate the emission of the
faulty selected T lymphocytes, the disease stops.
Dichotomic Nature of Atopic Dermatitis Re£ected by Combined Age-Related
Analysis of Peripheral T/CLA+ Lymphocytes and Serum IgE Levels
V. Bordignon, J.L. Sinagra1, E. Trento, P. Cordiali Fei, and B. Capitanio1
Laboratory of Clinical Pathology and 1Pediatric Dermatology Department ^ San Gallicano IRCCS ^ Rome, Italy
Background: The di¡erent pathogenetic mechanisms leading to the ‘‘intrinsic’’(low IgE) or to the
‘‘extrinsic’’ (high IgE) form of atopic dermatitis (AD) still have not been elucidated in the absence of
clear-cut data. Some authors have hypothesized that circulating or in¢ltratingT-CLAþ lymphocytes,
with a peculiar functional phenotype, may play a role in the pathogenesis of the two forms of disease.
Aim of the present work was to evaluate di¡erences in the peripheral T CLAþ levels in atopic pa-
tients with normal or elevated serum IgE.
Methods: 99 patients with AD were included in the study. The peripheral T-CLAþ numbers were
determined by £ow cytometry and analyzed in relation to age or index of disease acitivity (SCOR-
AD) in the 2 groups of patients with normal or elevated IgE levels.
Results: T-CLAþ cell numbers were signi¢cantly correlated with age (P¼ 0.04) in patients with ele-
vated IgE and not in those with normal IgE values (P¼ 0.53). Normal IgE levels were associated to
younger patients: 80.9%, 52% and 45.4% of patients with normal levels, in the three di¡erent age
group (o3, 3-15, 415 yrs) respectively.
Conclusion: Our age-related analysis supports the hypothesis that the two di¡erent forms of AD, are
charatcterized by di¡erent IgE levels but also by di¡erent age and di¡erent pattern of CLA expression
in T cells.
T-Cell Receptor Excision Circles (TREC) and Peripheral Turnover of T-Lympho-
cytes in Patients with Atopic Dermatitis.
H. Just1, M. Deleuran1, C.Vestergaard1, B. Deleuran2, and K. Thestrup-Pedersen1
1Department of Dermatology, Aarhus University Hospital and 2Department of Rheumatology, Aarhus University
Hospital
In order to investigate peripheral T-lymphocyte turnover in patients with Atopic Dermatitis (AD),T-
cell excision circles (TREC) was measured in di¡erent T-cell subpopulations. TREC is an episomal
DNA circle produced during T-cell receptor rearrangement and is used as a marker for recent thymic
emigrants (RTE). TREC content in CD4þ and CD8þ T-cells was measured in 43 patients and in
41 healthy controls. In ¢ve of the patients and one healthy control,TREC content was measured over
time. TREC content in CCR10þ T-cells, which are T-cells bound for the skin, was measured in
blood from four di¡erent AD patients in order to investigate if CCR10þ T-cells di¡er from
CCR10- T-cells.
The results showed signi¢cantly lower TREC content in both CD4þ and CD8þ T-cells from
male patients with AD compared toTREC content inT-cells from age matched healthy male donors.
No di¡erence was seen in TREC content in CD4þ or CD8þ T-cells from female patients and
female donors. CCR10þ T-cells had a three to twenty times lower TREC content than CCR10-
T-cells. TREC content measured over time indicated that AD patients have a large individual variance
in the number of peripheral RTE.These results suggest a massive turnover of peripheral T-lympho-
cytes in patients with AD compared to healthy donors. The lower TREC content in the skin homing
CCR10þ T-cells suggest that these cells are part of an active dividing population. Further studies of
TREC content over time and in di¡erent subpopulations are ongoing.
Increased CD123þ Dendritic Cells and IL-10 Expression in Lesional Skin of Atopic
Dermatitis
J.-S. Kim1, S.-W. Kim1, S.-H. Cho1, J.-W. Kim1, and J.M. Hani¢n2
1Department of Dermatology, College of Medicine,The Catholic University of Korea; 2Department of Dermatology,
Oregon Health Sciences University, Oregon, USA
The factors controlling in¢ltration of in£ammatory cells into atopic dermatitis (AD) lesions remain to
be fully explored. Recent studies have shown that there are two dendritic cell subpopulations, DC1
and DC2, which induce TH1 and TH2 cell di¡erentiation in vitro, respectively. To gain better insight
into the presence and distribution patterns of cytokine milieu as well as dendritic cell subpopulations
in lesional skin of AD. Our goal was to assess the association of IL-10 and IL-12p70 expressions with
DC2 and DC1 subsets respectively and association of IL-10 and IL-12p70 expressions with the in£am-
mation in patients with AD. To determine the percentage of labeled area with di¡erent cytokines and
dendritic cell subpopulations, immunohistochemical staining and digital imaging technique were
used. As compared with non-lesional skin of AD, there was a signi¢cant increased expression of
CD123þ DCs (p¼ 0.012) and IL-10 (p¼ 0.011) in severely in£amed lesional skin (n¼10), whereas
CD11c and IL-12p70 were not consistently decreased. Furthermore, CD123þDCs co-expressing intra-
cytoplasmic IL-10 were also present in the dermis of in£amed skin. Our data presented the predomi-
nance of CD123þ DCs and IL-10 in the lesional skin of AD and suggest the association of IL-10
expression with DC2 cells, known to be TH2-inducing DC subpopulaton. These cytokines milieu
and the abundant distribution of DC2 subpopulation may ultimately favor type 2 T lymphocyte-
dominated immunity.
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IgE- vs Non-IgE-Related Atopic Dermatitis
B.Wˇthrich
Allergy Unit, Dept. of Dermatology, University of Z rˇich,Switzerland
Atopic dermatitis (AD) is a multifactorial disease, caused among others by genetic conditions, alter-
ated skin structure, immunologic deviations and environmental factors. A subgroup of AD patients,
both children and adults, su¡er from a skin disease which clinically resembles the skin lesions and
distribution pattern of AD, but is not associated with sensitisation to aero- or food allergens and
shows normal total serum IgE levels and shows the absence of other atopic diseases such as allergic
asthma and rhinoconjunctivitis. In analogy to the extrinsic and intrinsic types of asthma, the author in
1983 had proposed the term intrinsic type of AD (IAD) as a counterpart to the extrinsic type of AD
(EAD). IAD is found in a relevant proportion of all AD patients; its frequency ranges from 10 to 40%.
Immunologic di¡erences between the two subtypes in cell and cytokine pattern can be located to
peripheral blood but mainly to the a¡ected skin  such as reduced capacity to produce IL-13 by skin
Tcells. Genetically and environmental caused di¡erences might be responsible for the variation of IgE
production. Positive atopy patch tests observed also in IAD patients point to the importance of T-cell-
mediated reactions. The new EAACI nomenclature propose now the terms of IgE-associated and non-
IgE-associated Atopic Eczema/Dermatitis Syndrome.The discrimination between the two suptypes of
AD is not just academic. The classi¢cation into an EAD (IgE-associated) and IAD (non-IgE-asso-
ciated) at each age phase (infancy, childhood, teen age, and adult phase is essential for the allergologi-
cal management of the patients (allergen avoidance, secondary allergy prevention). For the long-term
prognosis it’s therefore important to know that the risk of the development of an atopic respiratory
disease is much lower in IAD.
Wˇthrich B. Neurodermitis atopica sive constitutionales. Ein pathogenetisches Modell aus der
Sicht des Allergologen. Akt. Dermatol. 1983;9:1^7.
Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA,Wˇthrich B.Epidemiology, clinical fea-
tures, and immunology of the ‘‘intrinsic’’ (non-IgE-mediated) type of atopic dermatitis (constitutional
dermatitis). Allergy 2001;56:841^9.
B. Wˇthrich, P. Schmid-Grendelmeier. Natural course of the atopic eczema/dermatitis syndrome
after childhood. Allergy 2001;57:267^268
Intrinsic vs. Extrinsic Atopic Dermatitis: A Study on Diagnostic De¢nition and
Prevalence
S. Seidenari, and F. Giusti
Department of Dermatology, University of Modena, Italy
Our aim was to study the criteria employed to classify AD patients into the ‘‘intrinsic’’ or ‘‘extrinsic’’
AD group and to evaluate the frequency of these 2 forms among our patient population. 282 patients
with AD, 117 male and 165 female, underwent skin prick tests with 2 panels of aeroallergens and food
allergens, panel 1 comprising 11 substances and panel 2 including 66 allergens.We observed 171 positive
responses to panel 1, whereas the number of subjects reacting to panel 2 increased to 189. Thus a dif-
ferent percentage of our AD patients (61% and 67% respectively) could be considered a¡ected by an
extrinsic form of AD, depending on the number of tested allergens. Moreover, atopy patch tests with
20 aeroallergens and food allergens were performed in all patients. Among the subjects with negative
prick tests (93 ‘‘intrinsic’’cases), 68 reacted to atopy patch tests indicating a delayed ‘‘extrinsic’’ in£uence
of allergens on the dermatitis. Therefore, only 25 patients (9%) of our study population could be
classi¢ed as a¡ected by the intrinsic form on the basis of skin test results. Finally, in 18 subjects among
the latter we performed repeated oral food challenges with peanut, cow’s milk and egg, and observed
a positive response to egg in one patient. Thus one more patient was removed from the intrinsic group
and shifted to the extrinsic one. In conclusion, our ¢ndings demonstrate that the prevalence of the
intrinsic form of AD may be overestimated because of lack of adequate diagnostic work-up.
The Pivotal Role of Eosinophils in Atopic Dermatitis: Neuroimmunological
Interactions
A. Kapp, B.Wedi, and U. Raap
Dept. of Dermatology and Allergology, Hannover Medical University, Hannover, Germany
Studies over the past two decades have shown that eosinophils play a major role in atopic dermatitis
(AD), characterized by activated eosinophils in the peripheral blood and in the lesional skin. Several
lines of investigation indicate that eosinophils are recruited to and activated at tissue sites byTh2 cy-
tokines, such as IL-5 and IL-13. In addition, chemokines (Eotaxin, RANTES) also contribute to eo-
sinophil chemotaxis and activation. Moreover, interaction of eosinophil surface molecules and
endothelial cell VCAM-1 and ICAM-1 are important for eosinophil extravasation and activation. Pre-
viously, we could demonstrate an inhibition of eosinophil apoptosis in AD, probably mediated by an
autocrine release of IL-5, and GM-CSF. Once activated, the eosinophil is capable of releasing an arm-
ory of potent cytotoxic granule proteins and chemical mediators contributing to tissue in£ammation
as shown by the deposition of eosinophils products in the in£amed skin. Moreover, eosinophils may
have a key role in neuroimmunological interactions. Increased numbers of peripheral nerve endings
are in an active state of excitation in AD lesions, contributing to the intense itch torturing the pa-
tients. Indeed, vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and
substance P positive nerve ¢bres are prominently increased in lesional skin, mediating eosinophil ac-
tivation and chemotaxis. Moreover, hypertrophy of nerve ¢bers represents a characteristic feature of
AD skin lesions, due to an increased release of neurotrophins, such as nerve growth factor (NGF).
Neurotrophins as well as neuropeptides take their part in the crosstalk between the immune and per-
ipheral nervous system, modifying the functional activity of sensory neurons and immune cells, pro-
pagating a neurogenic in£ammation. Moreover, NGF itself is known for the inhibition of eosinophil
apoptosis and the increase of eosinophil cytotoxic activity. On the other hand eosinophils are capable
of NGF production, closing the regulatory loop of nerve activation. Taken together, the neuroimmu-
nological interactions between nerves and eosinophils clearly support the concept of a ‘‘neuroderma-
titis’’ in the ¢eld of AD.
Expression of Chemokine Receptors on Human Epidermal Langerhans Cells and
In£ammatory Dendritic Cells in Atopic Dermatitis Lesions
S.Wetzel, S. Decard and A.Wollenberg
Dept. of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany
Background: In£ammatory dendritic epidermal cells (IDEC) are a newly described DC subset accumu-
lating in the epidermal compartment of atopic dermatitis (AD) lesions.Whereas chemokine receptor
(CKR) expression of LC has been studied in normal human skin (NS), little is known about LC and
IDEC in AD lesions. Therefore, we investigated the expression of CKR on various DC types relevant
to AD lesions with a panel of monoclonal antibodies by di¡erent techniques.
Methods: Epidermal single cell suspensions were prepared from skin lesions by trypsinization. Freshly
isolated and short term cultured cell suspensions were analyzed by quantitative £ow cytometry. Other
in£ammatory skin diseases, NS, freshly isolated monocytes and monocyte-derived DC (MoDC)
served as control. In addition, cryosections were immunostained in APAAP technique for all CKR.
Results: In situ expression of CCR-6 was strongest on LC, whereas CCR2, CCR5, CCR6, CCR7 and
CXCR1were detected on IDEC. The in situ expression of CCR7 in in£ammatory skin, previously
attributed to LC, was restricted to IDEC. Upon maturation, LC and IDEC upregulated CXCR4,
whereas CCR5 and CCR6 were downregulated. CCR7 increased in LC and decreased in IDEC
upon culture. CKR expression was similar for psoriasis and AD with one exception: CXCR-3 was
signi¢cantly upregulated on IDEC in AD lesions. IDEC, MoDC and monocytes expressed CCR-5,
which is functionally important for cell migration from peripheral blood into the skin. MoDC down-
regulated their CCR5-expression upon terminal di¡erentiation, as induced by culture in LPS or
TNF-a.
Conclusion: IDEC showed a CKR pro¢le highly similar to monocytes, thus suggesting an ontogenic
link between both cell types. The expression of CCR5 supports our hypothesis of a de novo-immigra-
tion of IDEC in AD lesions. The di¡erent ultrastructure of LC and IDEC is mirrored by a distinctive
immunophenotype of the CKR repertoire and may be relevant for the accumulation of IDEC in AD
lesions.
FceRihigh Langerhans Cells and In£ammatory Dendritic Epidermal Cells Ascertain
a Di¡erent Outcome of T Cell Responses in Atopic Dermatitis
N. Novak1, B. Schlˇtter-B˛hmer1, S. Kraft2, B. Bohle3, S. La¡er3, R.Valenta3, J. Haberstok1, J.-P. Allam1,
and T. Bieber1
1Department of Dermatology, Friedrich-Wilhelms-University, Bonn 53105, Germany; 2Department of Pathology,
Beth Israel Deaconess Medical Center, Boston, USA; 3Department of Pathophysiology, AKH, University of
Vienna,Vienna, Austria
Atopic dermatitis (AD) is a biphasic in£ammatory skin disease characterized by an initial phase pre-
dominated byTh-2 cytokines which switches into a second and more chronic Th-1 dominated ecze-
matous phase. Two di¡erent FceRIhigh dendritic cell (DC) types, Langerhans cells (LC) and
in£ammatory dendritic epidermal cells (IDEC) have been identi¢ed in the epidermis of patients with
AD.These DC are believed to e⁄ciently monitor foreign antigens at potential sites of pathogen entry.
So far, the small amount of ex vivo isolated LC and IDEC available has hampered their detailed func-
tional analysis and consequently our knowledge about these DC.We have developed a novel in vitro
model which allows for the ¢rst time to study the respective FceRI-mediated mechanisms of LC and
IDEC in AD.We examined whether these DC subtypes de¢nitely contribute to the outcome of T cell
responses and consequently to the biphasic manner of this disease.We found that as an initial step,
FceRI-activated Langerhans cells (LC) release chemotactic signals such as monocyte-chemoattractant
protein-1 (MCP-1) and thereby recruit peripheral blood monocytes which are the precursors of
IDEC. More importantly, we have shown that LC induce aTh-2 typeTcell response that is character-
istic for the acute phase of AD. In a second step, FceRI-activated IDEC convert the initial Th-2 into a
Th-1 response and display a higher stimulatory capacity, implying that they amplify the in£ammatory
immune reaction in this way. The present study provides clear evidence that LC and IDEC contribute
distinctly to the outcome of T cell responses and the biphasic nature of AD. These ¢ndings are of
outstanding relevance in understanding the complex pathophysiological network of AD.
Stratum Corneum Lipids in Atopic Dry Skin
P.W.Wertz, and J. R. Hill
The University of Iowa, Iowa City, Iowa, USA
The dry skin of individuals with atopic dermatitis displays impaired barrier function as indicated by
increased transepidermal water loss and diminished water holding properties. Both of these biophysi-
cal anomalies can be related to altered composition of the lipids of the stratum corneum. Normal
human stratum corneum contains a series of nine structural types of ceramides, cholesterol and satu-
rated fatty acids as the major lipid classes. In addition, there are two major covalently bound cera-
mides. A number of previous investigations have documented altered lipid composition in the
stratum corneum of individuals with atopic dermatitis. There is general agreement that the total cer-
amide content of the atopic stratum corneum is decreased, the ratio of cholesterol to ceramides is in-
creased and the relative proportion of one speci¢c acylceramide, CER EOS in the nomenclature
system of Motta et al. (Biochim Biophys Acta 1182:147^151, 1993). CER EOS normally consists of
30- through 34-carbon o-hydroxyacids amide-linked to sphingosine bases and bears ester-linked li-
noleate on the o-hydroxyl group. This molecule appears to be essential for the organization of the
stratum corneum lipids and for barrier function. In addition to CER EOS, two additional acylcera-
mide types have been identi¢ed since the most recently published analysis of atopic stratum corneum
lipids - CER EOH and CER EOP (J Invest Dermatol 120:581-588, 2003). Our recent and more com-
prehensive comparison of ceramides from normal and atopic stratum corneum has revealed that the
proportion of CER EOP, like CER EOS, is decreased; however, the proportion of CER EOH in-
creased. Several other di¡erences were noted. In addition to the major structural lipids, normal stra-
tum corneum contains signi¢cant levels of free sphingoid bases. These molecules have broad
antimicrobial activity, and their production may be part of the innate immune system. The bases are
thought to be liberated through the action of ceramidases on ceramides. In atopic dermatitis, where
the content of ceramide substrate is lower than normal, sphingoid base content is also lower. This may
be related to colonization of the atopic skin by bacteria, particularly Staphylococcus aureus. Evidence will
be presented that when production of sphingoid bases from free ceramides is reduced, a ceramidase
partially compensates by hydrolyzing the amide linkage of the covalently bound ceramides.
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Keratinocytes Contribute to In£ammatory Circuits in Atopic Dermatitis
S. Pastore, and G. Girolomoni
Laboratory of Immunology, Istituto Dermopatico dell’Immacolata, IRCCS, Rome, Italy
Atopic dermatitis (AD) develops from a complex interplay of environmental, genetic, immunologic and
biochemical factors. Relevant to the ampli¢cation and persistence of in£ammatory and immune re-
sponses in AD skin is the contribution of keratinocytes, which can be induced to secrete pro-in£amma-
tory mediators in response to a variety of factors, including the epidermal barrier perturbation
characterizing this disease and the potent cytokines released by in¢ltrating leukocytes. Noteworthy, ker-
atinocytes from AD patients synthesize exaggerated amounts of chemokines and cytokines (e.g. GM-
CSF, RANTES,TNF-a), important for enhanced recruitment as well as sustained survival and activation
of DCs and T cells. A dysregulated cytokine production by epithelial cells can be primarily involved in
the pathophysiology of atopic diseases. The biochemical mechanisms underlying excessive production of
certain pro-in£ammatory mediators by epithelial cells are probably multiple. Experimental evidence in-
dicates that AD keratinocytes have a constitutive dysregulated activity of speci¢c constituents of AP-1
complex, known to be critically implicated in the control of the expression of numerous in£ammatory
genes, suggesting the existence of molecular, genetically predetermined mechanisms targeting atopic in-
£ammation to the skin. Studies using gene microchip array technology are currently underway to assess
whetherAD keratinocytes have an aberrant expression of in£ammatory genes. Inasmuch as epithelial cells
are an easily accessible target for therapeutic intervention, studies on the mechanisms that regulate expres-
sion of in£ammatory genes in epithelial cells may ultimately a¡ord new strategies for the control of AD.
TARC Augments TNF-a Induced CTACK Production in Keratinocytes Through
the CCR4 Receptor
C.Vestergaard, C. Johansen, U. Christensen, H. Just, T. Hohwy, and M. Deleuran
Department of Dermatology, Marselisborg Hospital, Aarhus County Hospital, University of Aarhus; Department
of Human Genetics, University of Aarhus, Denmark.
TARC (thymus and activation regulated chemokine) and CTACK (cutaneous T cell attracting chemo-
kine) are both pivotal mediators of the in£ammatory reaction in atopic dermatitis. TARC attracts
CCR4 positive T-cells known to be mainly of Th2 subtype whereas CTACK attracts skin homing
T-cells of both Th1 and Th2 subtype that express CCR10.We found that CTACK can be induced in
cultured human keratinocytes byTNF-a, but not byTARC alone. However, if the keratinocytes were
pre-incubated with TNF-a, TARC was able to augment the CTACK inducing e¡ect of TNF-a.We
also found that TNF-a induces CCR4 expression in keratinocytes. CTACK, nevertheless, was not able
to induceTARC production in the keratinocytes.We also investigated plasma concentrations ofTARC
and CTACK in plasma from 48 patients su¡ering from AD. This revealed that TARC and CTACK
concentrations in plasma correlate with each other, however they did not correlate with the SCOR-
AD scores of the patients. Surprisingly p-CTACK correlated inversely with EASI scores of the pa-
tients. This could be due to the treatment the patients received, as we also found that dexamethasone
inhibits the production of CTACK and TARC in keratinocytes. Our results suggest that the primary
Th2 dominated in£ammatory reaction in atopic dermatitis induced byTARC leads to an augmented
skin speci¢c in£ammatory reaction through CTACK.
Role of Staphylococcal Superantigen in Atopic Dermatitis: In£uence on
Keratinocytes
K.H. Kim, J.H. Han, J.H. Chung, K.H. Cho, and H.C. Eun
Department of Dermatology, Seoul National University Hospital, Seoul, Korea
S. aureus may play an important role in atopic dermatitis (AD) by secreting superantigens, such as
staphylococcal enterotoxins (SE) A or B and toxic shock syndrome toxin-1 (TSST-1). Dysregulated
cytokine production by keratinocytes (KCs) when exposed to staphylococcal superantigens (Super-
Ags) can be primarily involved in the pathophysiology of AD. We hypothesized that lesional KCs
from AD may react di¡erently to SuperAgs compared to nonlesional skin or normal skin from
nonatopics by producing more proin£ammatory cytokines such as IL-1a, IL-1b, andTNF-a.We com-
pared HLA-DR expressions in lesional skin versus nonlesional or normal skin by immunohistochem-
istry (IHC).We performed MTT test with cultured KCs from lesional, nonlesional, and normal skin
after adding SEA, SEB and TSST-1.We also compared levels of IL-1a, IL-1b, and TNF-a. secreted by
cultured KCs by ELISA. IHC showed that expressions of HLA-DR increased signi¢cantly in the
epidermis of lesional skin versus nonlesional or normal skin. Each concentration of SEA, SEB and
TSST-1 showed neither proliferative nor toxic e¡ect on cultured KCs by MTT. The secretions of
IL-1a.., IL-1b and TNF-a increased signi¢cantly in cultured KCs from lesional skin versus nonlesional
or normal skin after adding SEA, SEB and TSST-1. Our result suggested that KCs from lesional skin
react di¡erently to SuperAgs maybe due to increased expression of HLA-DR and the increased
productions of proin£ammatory cytokines in response to SuperAgs play a pathogenetic role in AD.
FK506 Up-Regulates Transforming Growth Factor- and Down-Regulates Consti-
tutive and Inducible Nitric Oxide Synthase on Cultured Human Keratinocytes:
New Insights on How Tacrolimus Ointment Interacts with Atopic Skin
C.-C.E. Lan, H.-S. Yu, and G.-S. Chen
Kaohsiung Medical University, Department of Dermatology, Kaohsiung,Taiwan
Tacrolimus ointment (FK506) has been used in recent years for treatment of atopic dermatitis (AD)
with favorable results. The direct e¡ects of FK506 on keratinocytes (KC) are investigated in terms of
transforming growth factor-beta (TGF-b) and nitric oxide synthase (NOS), both constitutive (NOS-
1) and inducible forms (NOS-2), as lowTGF-b and high NOS expressions are implicated to partici-
pate in the pathogenesis of AD. Our results showed that on FK506 treated KCs, theTGF-b releases are
up-regulated, particularly in the presence with tumor necrosis factor-alpha (TNF-a), while the ex-
pressions of NOS-1 and NOS-2 are down-regulated. Moreover, the gene expressions of NOS-2 are
down-regulated in a dose-dependent manner. These ¢ndings suggest that FK506 has direct e¡ects on
KC that probably contribute to its therapeutic e⁄cacy on treatment of AD.
The Role of Infection in Atopic Dermatitis
D.Y.M. Leung
National Jewish Medical and Research Center, Denver, Colorado, USA
This presentation will examine the role of infection in the pathogenesis of atopic dermatitis acting not
only as an exacerbating factor but also having skin disease-sustaining e¡ects resulting from its pro-in£am-
matory properties. Much of the research has focused on Staphylococcus aureus, which appears to mediate its
proin£ammatory e¡ects at least in part due to the production of potent exotoxins, e.g. superantigens. An
understanding of the mechanisms underlying enhanced S. aureus colonization and infection in atopic
dermatitis and identi¢cation of the molecules involved in triggering atopic skin in£ammation has impor-
tant implications in our current approach to the management of atopic dermatitis and the development of
new therapies for patients with this common skin condition. Recent studies suggest that the skin of pa-
tients with atopic dermatitis have increased binding avidity to S. aureus and is de¢cient in its ability to
generate antimicrobial peptides needed to eradicate bacterial and viral infectious agents. The mechanisms
for these altered properties in atopic skin appear to be due to a combination of the overexpression of Th2
cytokines and reduced production of certain proin£ammatory cytokines and chemokines. These observa-
tions are likely to account for their propensity to both bacterial and viral skin infections.
Natural History of Atopic Dermatitis ^ a Major Research Gap
H.Williams
Centre of Evidence-Based Dermatology, Nottingham, England
All clinicians know that the commonest questions asked by parents during a consultation of a child with
atopic dermatitis (AD) are ‘‘will he/she grow out of it?’’or ‘‘will he/she go on to develop asthma?’’.Yet, the
evidence-base for answering such common questions in 2003 is poor1. Even though at least 25 studies
have evaluated natural history of atopic dermatitis, the quality of studies is generally poor because of
inadequate sample size, poor disease de¢nition of the inception cohort, unclear de¢nition of relapse, short
follow-up, and large losses to follow-up. The only community-based cohort study estimated that 65% of
children who had eczema at 7 years were clear after 9 years. Prognosis of AD cases seen in hospital have
reported clearance rates of around 38% for children who were inpatients and 60% for outpatients. The
most consistent predictors for more persistent AD identi¢ed from 11 studies are: early onset of disease,
widespread disease in early life, concomitant asthma/hay fever and a positive family history. Seven studies
have evaluated development of subsequent asthma/hay fever and together, they suggest that around 50%
of children with AD seen in a hospital setting will develop asthma/hay fever. Three important conclu-
sions can be drawn from this current overview: (1) The prognosis of AD is not as rosy as many derma-
tology texts like to promulgate; (2) The generalisability of studies dealing with the natural history of AD
based on children born in the 1950s to today is questionable, since treatments and access to help has chan-
ged so much in the last 50 years; (3) There is a clear need to conduct high quality birth cohort studies that
examine the natural history of AD, eg through an observational arm of a birth cohort intervention study.
1.Williams HC,Wˇthrich B. The natural history of atopic dermatitis. In:Williams HC (ed.). Atopic
Dermatitis. Cambridge, Cambridge University Press, 2000, 41^59.
Evaluation of a New Sequential Treatment with an Association of Fusidic Acid and
Two Di¡erent Steroids
G.A.Vena on behalf of the ‘‘Fucidin/Fucicort Study Group’’
Unit of Dermatology, University of Bari, Italy
The role of microbial factors, especially of Staphylococcus aureus, in atopic dermatitis (AD) is of great
importance. In fact, skin colonization with S. aureus is notably increased in AD patients and may trigger
and/or exacerbate the in£ammatory network of AD. An open study aimed to evaluate the activity of an
antibiotic-glucocorticoid treatment in mild to moderate AD. For this purpose patients su¡ering from
localized forms of AD, with signs suggestive of potential microbial superinfections (oozing-crusting,
¢ssuring, excoriations), were selected. Treatment consisted of the application of fusidic acid associated
with betamethasone valerate (Fucicorts) twice a day for 10 days, followed by the use of a combination
of fusidic acid and hydrocortisone acetate (Fucidin Hs) b.i.d. for 10 days. Clinical evaluations were per-
fomed at baseline, after an appropriate wash-out period from previous active treatment, and after 10 and
20 days of treatment. The severity of skin signs and pruritus was assessed using a 4-point semiquantita-
tive scale. A total of 178 (105 male and 73 female) patients were enrolled in this study; of these, 42 were
adults, 87 were 3 to 15 years old, and 49 aged o3 years. At the baseline, AD was severity was mild in
67% of cases and moderate in 33%. Treatment was well tolerated. A relevant and progressive improve-
ment of AD signs and symptoms was noted throught the study treatment: AD severity was notably
reduced after the ¢rst 10 days and further improved after the subsequent phase. The patients’ or parents’
opinion on e⁄cacy and acceptability of the treatment was positive in most cases.
Impact of Airborne Pollen, Temperature and Humidity on Severity of Atopic Ec-
zema: Results of the First Population Based Panel Study in Children
H. Behrendt1, U. Krmer12, S.Weidinger13, U. Darsow13, M. M˛hrenschlager3, and J. Ring3
1Division of Environmental Dermatology and Allergology, Research Center for Environment and Health (GSF)/
Technical University, Munich; 2Institut fˇr Umweltmedizinische Forschung IUF, Dˇsseldorf; 3Department of
Dermatolology and Allergy,Technical University, Munich, Germany
Background: Atopic eczema is a multifactorial disease determined by genetic and environmental factors.
A relapsing course with seasonal variations is a well-known clinical feature in many patients. How-
ever, no study evaluating short-term variability of disease status caused by climatic factors or exposure
to airborne pollen has been conducted so far.
Methods: 43 children with atopic eczema from Augsburg (Germany) participated in a panel study be-
tween March and September 1999. These children had been identi¢ed in a cross sectional study on all
school-beginners in 1996. Results of RAST and prick test were available. Children daily recorded itchi-
ness (1: absent to 5: very intense), extension (% of body surface) and possible trigger factors. Indoor and
outdoor temperature and humidity as well as atmospheric concentrations of pollen grains were mea-
sured daily too. The association between symptom-scores and temperature, humidity and pollen counts
were analyzed using mixed linear models, taking the individual time series structure into account.
Results: The symptoms showed two contrasting temporal patterns. Half of the children had symptoms
mainly during spring time, when the study started, and were nearly symptom free in summer. The
other children exhibited slightly more symptoms in summer than in spring and were negatively af-
fected by increases of local temperature. These later children additionally showed signi¢cantly higher
symptom scores at days with high grass pollen load. This association was especially pronounced for
children sensitised against grass pollen (n¼ 8). Itchiness was one point higher (standard error 0.3,
po0.001) for an increase in grass pollen counts of 300 pollen/m3.
Conclusion: Disease expression of atopic eczema is in£uenced by climatic factors. Di¡erent subgroups of
patients may be distinguished according to particular a¡ection patterns. Exposure to airborne pollen
causes signi¢cant aggravation of eczema symptoms in sensitised patients. Consideration of the indivi-
dual type of eczema may help to arrange appropriate preventive and therapeutic measures.
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How ‘Atopic’ is Atopic Dermatitis? A Comparison Between Hospital and Commu-
nity Populations
C. Flohr
Centre of Evidence Based Dermatology Queen’s Medical Centre, Nottingham, England
Background: The association between atopy and atopic dermatitis remains controversial. This debate has
mainly focused on hospital based studies.
Objectives: To compare the prevalence of atopy between hospital and community populations and to
estimate the relative risk of atopy in atopic dermatitis, a systematic review of the literature was con-
ducted.
Methods: Papers were identi¢ed through systematic searches of Medline, supplemented by an extensive
hand search. Only cross-sectional surveys that measured the prevalence of atopy as skin prick test po-
sitivity or RAST class were included. The mean prevalence of atopy and atopic dermatitis as well as
the relative risk for atopy in atopic dermatitis were calculated.
Results: In hospital studies (n¼14), the mean prevalence of atopy was 63% among patients with atopic
dermatitis (range: 44.4^100%) in comparison to a mean of 36.2% in community populations (n¼ 9,
range: 7.4^78.3%). In healthy community controls the mean atopy prevalence was 21% (range: 4.3-
76.3%). The odds ratio for atopy in atopic dermatitis in community surveys varied between 1.1 and
5.27. In addition, a number of population based studies comparing di¡erent populations suggest that
skin prick test positivity can be common in areas where atopic dermatitis is rare. Furthermore, skin
prick test positivity can decrease over time in the same population, while the prevalence of atopic
dermatitis increases.
Conclusions: The association between atopy and atopic dermatitis is less strong than previously sug-
gested by hospital based studies. Moreover, comparisons across populations and over time indicate
only a weak and inconsistent association between atopic dermatitis and atopy.
Atopic Dermatitis and Varicella Skin Manifestations
G. Castelli Gattinara, P. Palma, A. Diociaiuti, and M. El Hachem
UnitaØ Operativa di Immunoinfettivologia ^ AIDS,
UnitaØ Operativa di Dermatologia Dipartimento di
Medicina Pediatrica ^ Ospedale Pediatrico Bambino GesuØ , Roma, Italy
Varicella is a common infectious disease with a typical exanthem, usually benign and self-limited.
Complications are believed to be rare, most being mainly reported in immunocompromised children
and less frequently in immunocompetent children. Cutaneous manifestations are among the most
frequent complications.We report in the present study 10 children with atypical and complicated var-
icella skin manifestations in atopic, immunocompetent children. During the last 3 years 10 children
with serious skin complications were admitted to our hospital. Patients’ median age was 4.5 years:
none was immunocompromised, but all were a¡ected by atopic dermatitis, not necessarily severe.
The observed manifestations could be divided into two groups: a. atypical varicella (bullous lesions
(2), haemorragic-necrotizing lesions (3)); b. complicated varicella (secondary bacterial infection (3),
necrotizing fasciitis (1), bullous erythema multiforme (1)). All of these children underwent treatment
with acyclovir and intravenous antibiotics with prompt resolution of the symptoms and without se-
quelae. Conclusions: Severe and unusual varicella complications normally described in immunocom-
promised children can be observed also in those with atopic dermatitis, even in the mild form. Skin
changes resulting from atopic dermatitis or altered local immunity are likely to lead to unusual man-
ifestations. Careful follow-up and adequate treatment are necessary to avoid sequelae and lethal com-
plications. This observation prompts the study of the immunological characteristics of skin reactivity
of atopic and immunocompromised children.
Eczema Herpeticum
A.Wollenberg, and S.Wetzel
Dept. of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany
Patients a¡ected by atopic dermatitis (AD) tend to develop common viral infections more frequently
than non-atopics. The morphology of these infections does not di¡er between atopics and non-ato-
pics, and they are treated similarly in both patient groups. In addition, disseminated infections occur
in AD, which are predominantly caused by members of the herpesvirinae, molluscipoxvirinae and
orthopoxvirinae genus.Whereas the clinical characteristics of the relevant disseminated viral infections
and the appropriate diagnostic procedures are largely known, some novel therapeutic options should
be considered. Among these infections, Eczema herpeticum (EH) is a clinically distinctive herpes sim-
plex virus infection of eczematous skin, which occurs almost exclusively in AD patients. Two studies
have recently been performed to identify the clinical and cellular factors predisposing for EH, which
had been largely unknown. First, a retrospective analysis of 100 EH patients and of 105 control patients
with AD was performed to identify the clinical features associated with EH: Fever and lymphopenia
were associated with EH as such, whereas an elevated ESRwas frequently seen in impetiginized con-
trol patients, too. The EH cases consisted of both primary and secondary HSV infection. EH patients
had a signi¢cantly earlier onset of their underlying AD and a signi¢cantly higher serum-IgE level
than AD control patients. Unexpectedly, more than 75% of the EH patients had not received any
corticosteroid treatment in 4 weeks prior to EH onset. In conclusion, the clinical risk factors for EH
are those associated with severe AD, and the majority of EH occurs in patients with untreated AD,
arguing against a role for topical corticosteroids in EH. Second, we hypothesized a pathogenic role of
plasmacytoid dendritic cells (PDC) in EH, which produce large amounts of type-I-IFN upon recog-
nition of viral infection. The presence of PDC and other dendritic cells was investigated in epidermal
single cell suspensions of lesional skin from di¡erent in£ammatory skin diseases and controls. Langer-
hans cells were found in normal and in in£amed skin samples. In normal skin PDC and in£ammatory
dendritic epidermal cells (IDEC) were low or absent. Psoriasis and contact dermatitis contained rela-
tively high numbers of both IDEC and PDC. Lupus erythematodes was characterized by high num-
bers of PDC but low numbers of IDEC, whereas IDEC but only very few PDC could be detected in
AD lesions. In conclusion, PDC and IDEC are selectively recruited to di¡erent skin lesions, and the
lack of PDC in AD lesions may predispose AD patients for EH.
Th1 and Th2 Cytokine Messenger RNA Expression in Lesional Skin of Atopic Der-
matitis Patients with and without Very High Serum Ige Levels
H. Sugiura,T. Tazawa,T. Uenishi, M. Uehara, H. Ebise, and T. Kimura
Dept. of Dermatology Shiga University of Medical Science; Genomic Science Laboratories, Sumitomo
Parmaceuticals Co., Ltd, Japan
Background: Some atopic dermatitis (AD) patients show elevated serum IgE levels, while others do not.
Purpose: We compared the di¡erences in mRNA expression of Th1 and Th2 cytokines, between AD
patients with and without very high IgE levels.
Materials and methods: An RT-PCR method was used to detect Th1 (IL-12p35, IL-12p40, IFNg, IL-18)
and Th2 (IL-4, IL-13) cytokine mRNA. The subjects were 25 AD patients with very high serum IgE
levels (42000 IU/ml), 6 AD patients without (o2000), and 6 healthy controls.We also employed a
genome-wide gene chip study to detect 90 types of Th1,Th2 and other a⁄liated cytokines.
Results: In patients with very high IgE levels, IFNg mRNA expression was detected in 9 of 25 AD
lesions by RT-PCR, while those without IFNg expression frequently corresponded to those without
IL-12 expression. IL-12p35 in AD lesions was signi¢cantly down-regulated as compared to normal
controls. IL-18 was detected in lesions from all 25 patients and IL-13 in 24 of 25, whereas IL4 in only
3. The expressions of Th1 and Th2 were similar between patients with and without very high IgE
levels. In the gene chip study, we failed to detect any Th1 or Th2 genes that showed a greater than
two-fold change of expression between two groups.
Conclusions: In lesional skin of AD patients with and without very high IgE levels, a very limited ex-
pression of IL-4 mRNAwas detected. Further, IL-18, IL-12p40, and IFNg mRNA expressions were
similar to those in normal controls.
Delayed Type Hypersensitivity Reactions to Pollen Derived Factors
K. Eyerich1, J. Huss-Marp12, U. Darsow12, J. Ring2, H. Behrendt1, and C. Traidl-Ho¡mann12
1Division of Environmental Dermatology and Allergy, GSF/Technical University Munich; 2Department of
Dermatology and Allergy Biederstein,Technical University Munich, Germany
DTH-reactions to epicutaneous application of aeroallergens is well documented in a subgroup of pa-
tients with atopic dermatitis. Recently we demonstrated that pollen apart from the allergen also re-
lease a variety of bioactive lipid mediators. To delineate the e¡ect of pollen-derived factors on human
skin we performed patch tests with native pollen grains and their aqueous extracts. 3 patients with
atopic dermatitis, sensitisation to grass and birch pollen and positive APT-reactions were chosen for
the study. 3 healthy individuals served as control. Pollen grains (grass and birch) were exposed with
petrolatum as carrier. Patch test rest reactions were graded according to the Guidelines of the Eur-
opean Task Force on Atopic Dermatitis.
Biopsies were taken from eczematous lesions after 48 and 72 hours and investigated by immuno-
histochemistry. Histology of positive pollen patch tests (PPT) showed signs of acute dermatitis with
keratinocyte damage and a marked in£ux of mononuclear cells into dermis and epidermis (90%
CD4þ , 30% CD25þ , 90% CD45ROþ ).
In negative patch test reaction a scarce in£ux of mononuclear cells was observed (50% CD4þ ,
90% CD45ROþ ). Concerning CD1a no di¡erence could be observed in the epidermis of positive
and negative PPTwhile in positive PPTa higher e¥ux of CD1aþ cells into the dermis was observed.
In this study we demonstrated that pollen derived factors induce eczematous skin reactions in terms of
DTH-reaction in susceptible individuals. Further studies will be necessary to reveal the underlying
molecular mechanisms and importance of bioactive lipid mediators in the course of this reaction.
Atopy Patch Test with House Dust Mite Allergen - an Ige Mediated Reaction?
M. Tengvall Linder, L. Holm, G. Matuseviciene, and A. Scheynius
Dept. of Dermatology, Stockholm S˛der Hospital and Unit of Clinical Allergy Research, Dept. of Medicine,
Karolinska Hospital and Institutet, Stockholm, Sweden
The eczema reaction in the atopy patch test (APT) is proposed to be IgE mediated, but can take place
in individuals lacking allergen-speci¢c IgE in serum.We evaluated the importance of allergen-speci¢c
s-IgE for the APT reaction. Ten patients with reproducible positive APT to extract of Dermatophagoides
pteronyssinus, 5 patients with (group A) and 5 patients without (group B) detectable s-IgE to D. pter-
onyssinus, were tested on normal skin of the back for 6, 24, 48 and 72 h. Skin biopsies were and ana-
lysed for cell in¢ltrates, eosinophils (EG2), IgE, FceRI, CD1a, CD4, CD8 and metalloproteinase 9
(MMP9). The dermal cell in¢ltrate scores did not di¡er signi¢cantly between the groups at any time
point. The number of IgEþ , CD4þ, EG2þ and MMP9þ cells increased with time in group A.
FceRIþ cells and CD8þ cells increased with time in both groups. A correlation was found between
the levels of D. pteronyssinus-speci¢c s-IgE and the score of dermal cell in¢ltrates at 72 h. The three
patients with the highest values of allergen-speci¢c IgE also had the highest expression of EG2þ cells
and the highest APT scores. Our study strengthens the hypothesis that the IgE molecule has a key
role, at least as an ampli¢er, in the APT reaction.
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Atopy Patch Tests with House Dust Mites in Patients without Atopic Dermatitis
F. Giusti, and S. Seidenari
Department of Dermatology, University of Modena and Reggio Emilia, Italy
So far the issue of atopy patch tests (APTs ) in subjects not a¡ected by atopic dermatitis (AD) has been
poorly investigated and with contrasting results. Our aim was to assess the frequency and intensity of
responses to APTs with mite allergens in non-AD subjects, and to compare these data to the ones
observed in AD patients. Patch tests were performed employing a mix of Dermatophagoides ptero-
nyssinus/farinae on 75 non-AD subjects, including 33 patients with allergic rhinitis and 42 healthy
volunteers, and on 66 AD patients. Positive reactions were observed in 24% of non-AD subjects and
in 44% of AD ones. The former showed responses of lower intensity (mean score¼1.3) than AD
patients (mean score¼1.9). Thus, positive responses to mite patch tests are observable also in subjects
not a¡ected byAD, but their frequency and intensity are signi¢cantly (po0.05) lower with respect to
AD patients. Delayed skin reactivity in non-AD subjects may be regarded as equivalent to the ¢nding
of speci¢c IgE by skin prick tests or RAST in healthy subjects, indicating an atopic state. For the
occurrence of both the induction and the elicitation of the dermatitis other skin factors should prob-
ably be concomitant.
Response to Mite Patch Test in Subjects With or Without Atopic Dermatitis
A. Belloni Fortina, F. Marciani Magno, I. Romano, E. Tonin, A. Salvadori, and A. Peserico
Dermatology Unit, Department of Pediatrics, University of Padova, Italy
Background and aims: Only few data are available on the frequency of positive responses to atopy patch
tests with Dermatophagoides in children not a¡ected by atopic dermatitis (AD).We currently include
a routine patch test with Dermatophagoides in our pediatric standard series. In this study we investi-
gated the prevalence of contact sensitisation to mite allergens in a cohort of 213 consecutive paediatric
patients.
Patients and Results: 124 children (o18 years) out of 213 (58.2%) showed a positive allergic response to
patch test with Dermatophagoides. Among these patients, 71 (57.3%) children were a¡ected by AD,
whereas the remaining 53 (42.7%) patients were subjects without AD. Each patient with positive patch
test to Dermatophagoides underwent prick test with an aeroallergen series including Dermatopha-
goides. Among the 71 children with AD and positive allergic response to Dermatophagoides, 18
showed positive prick test to Dermatophagoides, 17 to other aeroallergens and 36 were negative.
Among the 53 non-AD children sensitized to Dermatophagoides, 15 showed positive prick test to
Dermatophagoides, 14 to other aeroallergens and 24 were negative. 9 out of these 24 non-AD patients
showing positive patch test but negative prick test to Dermatophagoides had no personal or familial
history of atopy.
Conclusions: Our preliminary results suggest the usefulness of performing routinary patch testing to
Dermatophagoides in the evaluation of contact allergy also in children not a¡ected by atopic derma-
titis.
The Utility of Atopy Patch Test for Diagnosis of Adverse Reactions to Food in
Children with Atopic Dermatitis
L. Brunetti, P. Fiermonte, F.Valerio, R. Tesse, C. Massagli,V. De Sario, C. Nardelli, F. Fiore, and L.
Armenio
Department of Pediatrics, University of Bari, Italy
Background: Atopic dermatitis (AD) is frequently associated with food allergy. Adverse immunologic
reactions to food may be a consequence of both IgE- and non-IgE-mediated mechanisms. Non-IgE-
mediated allergic responses tent to involve aT-cell mediated delayed hypersensitivity reaction that can
be evaluated by the atopy patch test (APT). The aim was to evaluate the diagnostic value of the APT
with regard to late-phase reactions observed in double blind, placebo-controlled food challenges
(DBPCFCs) with cow’s milk, hen’s egg, wheat, in children with AD.We hypothesized that a positive
APT result would render DBPCFC unnecessary.
Methods: One hundred and thirteen children [69 males, median age 4.2 years (range 4 months-12.7
years)] su¡ering from AD and suspected food-related clinical symptoms were investigated with
APT and DBPCFCs.
Results: Of 229 DBPCFCs, 24 (40%) were assessed as positive for cow’s milk, 32 (53%) for hen’s egg, 4
(7%) for wheat. Out of 42 patients with APT positive reactions, 20 (53.8%) had positive response to
hen’s egg, 4 (10.8%) to milk, 4 (10.8%) to wheat, 12 (32.3%) to milk and egg, 2 (5.4%) to milk and
wheat.We found that late-phase clinical reactions were associated with a positive APT; the sensitivity
to cow’s milk was 64%, to hen’s egg 86%, to wheat 100%; the speci¢city was 86% for milk, 73% for
egg and 95% for wheat; positive predictive value was 47% for milk, 22% for egg, 40% for wheat;
negative predictive values were 93%, 98% and 100% respectively.
Conclusions: Our ¢ndings con¢rm that the APT may be a valuable additional tool in the diagnostic
work-up of food allergy in children with AD because of its high speci¢city and sensibility for late-
phase clinical reactions, however DBPCFC must be still considered the diagnostic gold standard test.
No Standard in the Gold Standard for Food Allergy Diagnosis: An Italian Pediatric
Survey
A Fiocchi, A. Martelli, P. Isoardi, R. Arancio, and O. Marelli
Melloni University Hospital, Paediatrics, Milan, Italy
Background: Food allergies are among the earliest manifestations of atopy. Food allergy diagnostic pro-
tocols rely on the reference standard of double-blind, placebo-controlled, oral food challenge
(DBPCFC); however, there is no standard procedure for the provocation text itself. In order to picture
conditions under which oral food challenges are administered in Italy, a nation-wide questionnaire
survey of hospital-based allergy centres was administered between January 1st and June 30th, 2003.
Methods: All in-hospital allergy centres received a questionnaire in 23 points detailing organisation and
procedures followed during direct provocation tests. Facilities, workloads and medical personnel in-
volved were investigated. Study allergens, preparations of challenge meals, blindness and placebo were
also polled.
Results: 375 responded out of 536 healthcare facilities with a paediatric department in activity in 2002.
61% per cent of responders had the facilities to mount direct provocation tests. Among these, frequen-
cies of 85 and 15 per cent respectively for open and variously blinded procedures were recorded. Of
centres that o¡ered blinded tests, no uniform procedures are followed. In cow’s milk testing, few cen-
ters used an amino acid mixture as placebo. Other placebos include lyophilised cow’s milk capsules,
soy formula, extensive whey hydrolysate or extensive casein hydrolysate.
Conclusion: The picture this nationwide survey reveals is a variety in provocation test criteria, facilities
and procedures. This argues in favour of greater standardisation on a transnational, European scale.
These data further suggest that resorting to provocation tests in the work-up of food allergy is widely
felt and appreciated.
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Management of Atopic Dermatitis in France (2001-2002): A Questionnaire Survey
D. Coustou, C. Brun-Strang, F. Boralevi, and A. Ta|« eb
Research and Development, Novartis-Pharma SAS, Rueil-Malmaison; Health Economics, Novartis-Pharma
SAS, Rueil-Malmaison; Dept. of Dermatology and Pediatric Dermatology Unit, Bordeaux, France
The management of atopic dermatitis (AD) is not yet standardized, primarily due to the various med-
ical specialists in charge of patient treatment. To evaluate the management of AD in the French popu-
lation, we conducted a cross sectional study in 2002.
Methodology: A representative sample of 4012 French households were interviewed by phone. The in-
terviewed sample population was representative, as indicated by the quota method after strati¢cation
by region and community signs (socio-professional category). First, 190 AD patients were selected
through the reading of a precise disease de¢nition, adapted in French from the criteria of the UK
working party. Next, data were collected in these 190 patients using self administered questionnaires
and phones contacts. Patients were asked about the medical management of their AD, the treatments
provided and the severity of their last disease £are (body area involved, intensity of 6 objective signs
ranked from 0 to 3). An objective self administered SCORAD was calculated for the last £are of each
patient. Finally, data were adjusted (statistical recti¢cation) to be representative of the French popula-
tion in terms of sex and age.
Results: Among the 190 patients with AD, 105 were children. The group divided into 22 0 to 2 years
old, 52 2 to 5 years old, 31 5 to 15 years old and 85 patients of more than 15 years. 90.6% of patients
consulted a physician during the last year, with means values of 7 times for children and 5 times for
adults. Adults and, to a larger extent, children consulted several physicians for their condition (29% of
adults and 44% of children).When only one physician was consulted, general practitioners were cited
¢rst (33% in adults, 32% in children), while the remainder divided between pediatricians and derma-
tologists. None of the patients interviewed had been hospitalized for AD during the last 12 months.
76% of patients used topical corticosteroids (TCS) during the last 6 months. TCS used were classi¢ed
as low potent in 2.8%, moderately potent in 30.7%, potent in 75.4%, and very potent in 9.9%. The
mean duration of TCS use during the last £are was 14 days corresponding to a mean consumption of
21 g and a median of 7 g. Over the last six months, the monthly consumption of TCS was 12.5 g and
the median was 7.8 g. Correlation betweenTCS dose, age of patients and AD severity are represented
in Tables 1 and 2.
13% of patients used TCS continuously. Among TCS users, 10% discontinued treatment because of in-
tolerance, while 41% had safety concerns and self limited the amount applied. 76% of patients used
emollients during the last six months. The mean duration of emollient use during the last £are was 26
days, corresponding to a mean consumption of 168 g. Over the last six months, the monthly consump-
tion of emollients was 85 g. 75% of patients used emollients during remission periods.
Conclusions: Our data show that the use of TCS during £ares associated with continuous use of emol-
lients remains a therapeutic mainstay. This is one of the ¢rst studies to report quantitative data con-
cerning topical treatments in AD and their correlation with age and severity score (SCORAD). There
is no signi¢cant di¡erence between the di¡erent age groups concerningTCS dose. However, there is a
real correlation with the severity of the disease. This study underscores patient concerns whenTCS are
used. Specialist visits are available in France for the majority of patients, one possible explanation for
the absence of hospitalized patients. Our data show that there is no standard regimen for TCS pre-
scription, and that progressive tapering of TCS use is not common in the majority of patients. Our
study clearly indicates a need for practical guidelines for long term disease management.
Leukotriene Receptor Antagonists - a Novel Therapeutical Approach in Atopic
Dermatitis?
M.K. Kgi
Dermatology, Allergy and Immunology FMH, Zurich, Switzerland
Cysteinyl leukotrienes (LTs) play an important role in the pathogenesis of the in£ammatory response
in atopic diseases such as allergic asthma and allergic rhinitis. Recent experimental ¢ndings suggest
that cysteinyl LTs may also be important in the pathogenesis of AD. Therefore, bene¢cial e¡ects of 5-
lipoxygenase inhibitors and LT receptor antagonists (LTRA) may be expected if used in the treatment
of AD. Indeed, signi¢cant improvement of skin manifestations in atopic dermatitis has been published
with leukotriene receptor antagonists recently. Newer data and own clinical experiences however sup-
port the fact, that LTRA’s are not e¡ective in severe AD patients and therefore are not generally re-
commended for the treatment of AD. In my presentation, I will review the experimental and clinical
experience gained in treating atopic dermatitis with montelukast and other leukotriene receptor an-
tagonists (LTRAs) ^ focusing on the question whether Montelukast and other LTRAs are valuable
therapeutic options in the treatment of mild to moderate AD, especially when associated with other
atopic diseases such as asthma and allergic rhinitis, and in some subgroups of AD such as atopic der-
matitis of the face. In addition, pro’s and contra’s of a new therapeutic option ^ namely the combina-
tion of topical calcineurin inhibitors and systemic LTRA’s will be discussed.
‘Wet-Wrap’ Treatment with Diluted Corticosteroids and Emollients in Atopic Der-
matitis and the Dermatitis Lesion-Free Diaper Area
A.P. Oranje
Dept of Dermatology (Pediatric Dermatology), ERASMUSMC, Rotterdam, Holland
‘Wet-wrap’ dressings with diluted corticosteroids form an intensive treatment in children and adults
with erythrodermic and refractory severe atopic dermatitis (AD). The most important side e¡ect is a
(temporary) suppression of the hypothalamus-pituitary-adrenal cortex-axis that occurs in less than 5%
of the patients. Further diluting of the corticosteroid cream from 25 - 5% diminishes this risk, whilst
a good e⁄cacy is maintained. Steroids with an increased bene¢t ^ risk ratio such as mometasone
furoate and £uticasone propionate cream are preferably used. Long-term treatment at home is feasible
when patients (and their parents) are well motivated and are provided with adequate instruction and
guidance. A marked improvement of AD skin lesions is noted in all patients. The e¡ect is very quickly
achieved. As well in children as in adults, an improvement of 80% is achieved within one week after
intensive treatment. Substitution of tubifast bandages by garments (‘‘wet wrap pyjama’’) will improve
the results and handy application. The modern disposable diaper acts also as a wet wrap: the diaper
skin is usually free of AD skin lesions. Our studies performed in 1986 (Tio et al, 1988) showed that
TEWL is higher in the diapered skin. This was recently con¢rmed by an unpublished study with
the most advanced diapers (Odio ^ personal communication, 2001). In the diagnostic criteria of Samp-
son this can be used as diagnostic item.
Comparison of Self-Management Plans for Atopic Dermatitis and Asthma
J.M. Spergel1, M. Boguniewicz2, N.H. Nicol3, K. Timons4, and L.C. Schneider4
1Div. of Allergy and Immunolgy, Dept. of Pediatrics, Children’s Hospital of Philadelphia, Univ. of Pennsylvania
School of Med.,Philadelphia, PA; 2Div. of Pediatric Allergy-Immunology, Dept. of Pediatrics, National Jewish
Medical and Research Ctr. and Univ. of Col. School of Med., Denver, CO; 3National Jewish Medical and
Research Ctr and Univ. of Col. School of Nursing, Denver, CO; 4Div. of Allergy and Immunology, Dept. of
Pediatrics, Children’s Hospital, Harvard University, Boston, MA, U.S.A.
Self-management plans for the treatment of atopic asthma are recommended by both the United
States (NHLBI) and European guidelines (GINA). 25 studies examining these written plans for the
treatment of asthma have shown improvement in control symptom free days, fewer emergency room
visits and lower costs of medical care.Written self-managements are recommended over medical man-
agement plans in the treatment of asthma in the latest NHLBI guidelines (July 2002). Despite the
similarities between the diseases, no self-management plans for the treatment of atopic dermatitis have
been published.We compared several asthma self-management plans with three independently devel-
oped self-management plans for atopic dermatitis. The majority of the asthma self-management plans
have 3 steps: every day medications, medications for beginning of symptoms and medications for
worsening symptoms. Several asthma management plans are color-coded and others have pictures to
help with individual with low reading ability. All three atopic dermatitis plans have initial levels of
therapies or maintenance. However, one plan has two steps of step-up therapies and the other plan has
3 levels of step-up treatment.While, the third plan develops separate levels of treatment depending on
the severity of underlying disease and includes one level of step-up therapy in the maintenance phase.
The plans varied in readability of the language. Neither plans used colors or pictures to help with
patients with low levels of reading ability. All plans have maintenance therapies but di¡er in the num-
ber of steps of increasing therapy and level of readability. Studies need to be developed to determine if
management plans in atopic dermatitis can increase symptom free days and lower costs similar to
asthma.
Table1. TCS consumption for the last £are in grams correlated with age of patients
All 15 years 415 years 5 years
Mean 21.38 22.85 19.83 24.67
Median 6.84 6.74 6.34 6.74
Table 2. TCS consumption for the last £are in grams correlated with severity of AD
Mild Moderate Severe
Mean 11.27 21.39 40.90
Median 3.10 7.15 18.61
severity of AD: evaluated using calculated objective self administered SCORAD (0 to 83) mild:
SCORAD o15; moderate: SCORAD¼15-40; severe: SCORAD440
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The Anti-In£ammatoryActions of H1-Antihistamines
G. Girolomoni, and M.L. Giustizieri
Istituto Dermopatico dell’Immacolata, IRCCS, Roma, Italy
Histamine is responsible for the vasodilation, increased vascular permeability and mucosal hypersecretion
tipical of IgE-mediated allergic diseases such as rhinitis, conjunctivitis and acute urticaria. Numerous ob-
servations however have ampli¢ed the contribution of histamine to a variety of in£ammatory and im-
mune responses. Histamine other then being stored by mast cells (MC) and basophils can be produced
(although not stored) by leukocytes and keratinocytes. In these cells, histidine-decarboxylase is rapidly
induced upon activation with cytokines (IL-1,TNF-a), bacterial products or UV radiation. The four his-
tamine receptors (H1-H4) are expressed by many cell types that participate to the development of immune
responses, including dendritic cells (DCs), monocytes,Tcells and epithelial cells. Histamine inhibits TNF-
a and IL-12, whereas increases IL-10 release from mature DCs and monocytes via activation of H2 and H3
receptors. As a consequence, DCs exposed to histamine more easily induce Th2 compared to Th1 cell
di¡erentiation. Histamine also directly a¡ects the functions of T cells, MC and eosinophils, as well as en-
dothelial and epithelial cells Anti-H1 antihistamines are widely used anti-allergic and anti-pruritus agents.
However, it is likely that these drugs exert anti-in£ammatory actions via both receptor-dependent (inverse
agonism) and receptor-independent mechanisms. Anti-H1 drugs block histamine release from MC and
basophils, and stabilize their cell membrane rendering them less sensitive to degranulating agents. More-
over, certain anti-H1 (desloratadine) suppress IL-4 and IL-13 production by MC and basophils. Anti-H1
inhibit accumulation and activation of in£ammatory cells in the skin and respiratory mucosae by inhibit-
ing the expression of chemokines and adhesion molecules. In murine models, anti-H1 and anti-H2 agents
accelerate epidermal barrier repair. Some of these activities may be secondary to the capacity of anti-H1 to
reduce NF-kB activation. In conclusion, anti-H1 histamines have the potential to exert e¡ective anti-in-
£ammatory actions not only in MC- or IgE-dependent diseases, but also in other disorders.
Combined Therapy in Atopic Dermatitis
E. Berardesca
San Gallicano Dermatological Institute, Rome, Italy
Topical corticosteroids have been the mainstay of treatment for atopic dermatitis. They induce several
changes in skin metabolism leading to reduction of in£ammation and itching and can be used both in
acute and chronic phases of the disease. Their mechanism of action is broad and complex, a¡ecting
several pathways of in£ammation and gene expression. Due to their potential side e¡ects and depend-
ing upon the clinical severity of the disease, their use should be limited to the acute phases and then
replaced by other treatments. Low to mild potency steroids should be preferred. Pulse steroid therapy
in association with emollients or barrier restructuring creams has been shown to be e¡ective, safe and
useful in keeping disease- free chronic patients. In particular, physiologic mixtures containing free
fatty acids, cholesterol and ceramides can penetrate a disrupted stratum corneum, reach the nucleated
epidermal cell layers and be incorporated into nascent lamellar bilayers of the stratum corneum inter-
stices. Clinical trials of ceramide-dominant barrier repair moisturizer has been shown to reduce the
severity scoring of atopic dermatitis, normalizing TEWL and improving stratum corneum integrity.
Combination therapy of mild corticosteroids with physiologic lipid mixtures can be a useful, low cost
and safe approach to the long term management of atopic dermatitis.
Selectivity as a Means of Extending the Therapeutic Window Provides Improved
Safety and E⁄cacy
T. Luger
Department of Dermatology, Mˇnster University, Mˇnster, Germany
Increased understanding of the pathophysiological mechanisms of in£ammatory skin diseases, such as
atopic dermatitis, has led to the development of treatment regimens that act early in the in£ammation
cascade and provide improved disease management and safety in both the short and long term. Pime-
crolimus cream 1% (Elidels) is a new, non-steroid, cell-selective in£ammatory-cytokine inhibitor
with an excellent safety pro¢le that di¡ers from both corticosteroids and tacrolimus. Pimecrolimus
is lipophilic, resulting in a high a⁄nity to the skin, and selectively inhibits the synthesis and release
of in£ammatory cytokines fromT cells and activated mast cells. Unlike corticosteroids, pimecrolimus
has no e¡ect on other immune-competent cells; has no atrophogenic potential when applied to hu-
man skin; and is safe for application on sensitive areas, such as the face and neck. Pimecrolimus pene-
trates well into the skin, but permeates through the skin less than tacrolimus and corticosteroids;
consequently, it has a lower risk of systemic side-e¡ects.When used at the ¢rst signs and symptoms
of atopic dermatitis in double-blind, controlled trials, pimecrolimus produces rapid relief from prur-
itus, erythema and in¢ltration, and prevents progression to £are in all ages and all disease severities.
The excellent safety and e⁄cacy of pimecrolimus, when considered together, extend the therapeutic
window for the management of atopic dermatitis.
Disease Management as aWay to Achieve Disease Modi¢cation
R. Langley
Division of Dermatology, Dalhousie University, Halifax, Nova Scotia, Canada
Atopic dermatitis (AD) is a chronic, persistent disease with a recurring pattern of £ares. Early preven-
tion of £ares has the potential to modify disease progression and the development of other atopic
diseases. Double-blind, controlled studies show that pimecrolimus cream 1% (Elidels), when applied
at the ¢rst signs or symptoms of AD, prevents progression to £are and thereby provides long-term
disease control.When used in all age groups, up to 61% of patients in the pimecrolimus group re-
mained £are-free, compared with 34% of patients treated conventionally (po0.001). Flare prevention
also results in a considerable reduction in steroid use; the majority of patients did not require steroids
for the duration of the studies (up to 1 year). Other studies have reported a high degree of cosmetic
acceptability with pimecrolimus cream 1% in daily practice, which is important for patient compli-
ance. Assessment of disease signs indicates that £are reduction is due to a reduced level of disease ac-
tivity following treatment with pimecrolimus cream 1%. AD is often the ¢rst manifestation of the
‘atopic triad’; up to 80% of children with AD will develop asthma or allergic rhinitis later in life.
Recent evidence indicates a common pathophysiological link between these diseases. A trial of early
and consistent use of pimecrolimus cream 1% is planned to test this hypothesis.
From ETAC to EPAAC
F.M. de Benedictis, F. Franceschini, and L. Pietroni
Department of Pediatric Medicine,‘‘Salesi’’ Childrens’ Hospital, Ancona, Italy
The prevalence of asthma, atopic dermatitis and allergic rhinitis has increased considerably over the past
decades, and there is a common progression from atopic dermatitis to allergic asthma (allergic march).1
Approximately 50% of children with atopic dermatitis in early infancy and who have both parents with
atopic disease will develop asthma at the age of 5 years.2 Cetirizine, a second generation anti-histamine,
has shown also some anti-in£ammatory, since it inhibits allergen-induced ICAM-1 expression in nasal
and conjunctival epithelium during allergic in£ammation3 and reduces eosinophil chemotaxis.4 The
ETAC study (EarlyTreatment of Atopic Child) was a 5 year prospective, randomized, double-blind, par-
allel group and placebo controlled trial involving 817 young children in 12 European Countries and Ca-
nada.5 The aim of this study was to investigate if treatment with cetirizine may prevent or delay the onset
of asthma in children (1-2 years of age) with atopic dermatitis and a family hystory of atopy. The study
was conducted in two phases, involving 18 mounth treatment period and 42 mounth follow-up period.
After the ¢rst 18 mounth study period, clinically relevant e¡ect of cetirizine in reducing development of
asthma was not shown in all patients, but only in children who were sensitized to grass pollen and/or
house dust mite at baseline. This e¡ect remained signi¢cant for children sensitized to grass pollen after
18 mounth follow-up period, while less e¡ect was shown in children sensitized to mite allergens.6 The
EPAAC study (Early Prevection of Asthma in Atopic Child) was recently initiated. The purpose of
EPAAC study is to provide the body of evidence that would con¢rm the ¢ndings generated by the sub-
group analysis carried out in ETAC, and to demonstrate that asthma can be prevented in young children
with atopic dermatitis sensitized to speci¢c aeroallergens. For this study levocetirizine, which is the active
enantiomer of cetirizine, will be used. 500 children (250 for group) are planned to be randomized in 80
Centers in Europe, Australia and South Africa. The trial includes 18 mounth treatment period and 6
month follow-up period after discontinuation of the trial medication. The study is currently in progress.
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The Size of Thymus and Atopic Dermatitis. A Cross-Sectional Study
A. Braae Olesen, G. Andersen, D.L. Jeppesen, C.S. Benn, S. Juul, and K. Thestrup-Pedersen
Dept. of Dermatology, Dep of Radiology, University Hospital of Aarhus, Denmark
Atopic dermatitis (AD) is a common skin disorder of unknown aetiology with peak incidence in early
childhood.The disease includes immune deviations such asT-cell accumulation and activation.Thymus is
a key organ for selection, accumulation and activation of the cellular immune response in early life.We
therefore wanted to study if there was any association between the size of thymus and current atopic
dermatitis. A cross-sectional study was performed. Thirty-seven in and out-clinic patients with current
AD were enrolled from the dep. of dermatology in Aarhus and compared to 29 healthy controls. An
interview and medical examination was performed by one doctor (ABO). For children with AD SCOR-
AD and the use of steroids were registered.Within 3 days after examination an ultrasound scan was per-
formed. The thymus index was obtained using a trans sternal approach. Sonography was performed by
one doctor (GA) with a Siemens scanner using a 7.5 MHz sector transducer. The size was signi¢cantly
increased in children with active atopic dermatitis compared with healthy controls (po0.05). The main
analysis showed that the thymus index declined signi¢cantly with age (po0.05) to a comparable degree
in both children with atopic dermatitis and healthy controls.The individual measurements showed a large
range in the size of thymus in both groups of children. There was no di¡erence among the two groups
concerning: breastfeeding, family size, time of introduction of ¢rst dietary supplement and daily care of
the child. This study demonstrates increased size of thymus among children with active atopic dermatitis
compared to healthy controls. In an earlier study we found no association between the size of thymus at
birth and atopic disease at the age of 5 (1). The increased size of thymus may be associated with increased
activity and emission of T lymphocytes.
1. Benn CS et al. Clin Exp Allergy 2001;31:1862^6
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Nitric Oxide in Atopic Dermatitis: a HPLC Method for the Simultaneous Mea-
surement of Arginine Metabolites
A.Volke1, and V.Volke2
1Dept. of Dermatology and 2Dept. of Physiology, University ofTartu,Tartu, Estonia
Nitric oxide (NO), a signaling molecule derived from L-arginine by NO synthase, is shown to have
potent immunomodulative properties. Several studies suggest its involvement in atopic dermatitis
(AD). Recently, it has been demonstrated that arginase and arginine decarboxylase, which also use
arginine as a substrate may regulate NO synthase activity and vice versa by competing to the L-argi-
nine. The presence of both arginase and NO synthase in the skin have been shown previously. We
aimed to measure the activities of NO synthase, arginase and arginine decarboxylase in normal and
AD skin as well as in peripheral blood mononuclear cells.We have developed an HPLC method with
radiochemical detection for simultaneous measurement of arginine, citrulline, ornithine and agmatine
after adding the radiolabeled arginine to the tissue or cell preparation.The compounds are separated in
normal phase column under isocratic conditions in less than 30 minutes with good sensitivity. Preli-
minary data will be presented and discussed in context of current concepts of the pathogenesis of AD.
Correlation of Clinical Features and Skin Barrier Function in Adolescent and Adult
Patients with Atopic Dermatitis
D.-W. Kim, J.-Y. Park, D.-J. Park, G.-Y. Na, S.-J. Lee, and S.-L. Chung
Dept. of Dermatology, Kyungpook National University School of Medicine, Daegu, Korea
Xerotic skin change in atopic skin is considered to be related with the diminished water-permeability
barrier. However, whether abnormal skin barrier function is a main cause of atopic dermatitis (AD) or
a secondary change of the disease is still controversial. Noninvasive bioengineering methods including
transepidermal water loss (TEWL) and water capacitances have been commonly used to evaluate skin
barrier function. Our objective was to evaluate the corrrelation of clinical features of each evaluation
site and skin barrier function by the severity of AD.We checked TEWL, capacitance and pH on 5
evaluation sites-postauricle, forearm, abdomen, thigh and popliteal fossa. The subjects were 25 pa-
tients, adolescent and adult, with AD and 25 age-matched normal controls.We also scored the clinical
severity from 0 (no clinical manifestations) to 3 (severe) for erythema, induration/population, licheni-
¢cation and xerosis on each evaluation site of the patients with AD. Based on the data, we found that
the clinical severity score is correlated withTEWL and capacitance in more than half of the evaluation
sites. Erythema and induration/population usually showed statistically signi¢cant correlation with
TEWL. Licheni¢cation and xerosis usually showed signi¢cant correlation with capacitance. However,
severity scoring of clinical features mostly did not show signi¢cant correlation with skin pH. The
patients had higher TEWL and lower capacitance than those in the normal controls.
Synthesis and Evaluation of the Novel Ceramide Analogue Based on L-Serine For
the Skin Barrier Repair
K.Vavrova, J. Zbytovska,T. Holas, J. Klimentova, A. Hrabalek, and P. Dolezal
Charles University, Faculty of Pharmacy, Hradec Kralove, Czech Republic
Stratum corneum ceramides are fundamental for maintaining the skin barrier function. The ceramide
content is decreased in several skin diseases including atopic dermatitis and ceramide supplementation
is one of the therapeutic approaches. However, the syntheses of ceramides are di⁄cult and expensive.
We designed novel ceramide analogue 14S24 and we report convenient two-step synthesis. The di¡er-
ence between 14S24 and ceramide 2 is only the presence of ester bond instead of hydroxyl in position
3 and trans-double bond in position 4 of sphingosine. Skin permeation experiments were performed
using porcine full thickness skin and theophylline as the model permeant. The experimental skin bar-
rier disruption was induced by lipid extraction. The permeability of the disrupted skin was signi¢-
cantly higher than that of the normal skin. This elevated permeability was reduced by 2 hours
topical application of the 0.1% 14S24 almost to the values of untreated skin. Ceramide analogue
14S24 is easier and cheaper to synthesize than physiological ceramides and it is e¡ective in skin barrier
repair in vitro. This ceramide analogue could be bene¢cial in skin diseases with impaired barrier func-
tion. This work was supported by the Charles University (grant 256/2001/B-CH/FaF) and the Minis-
try of Education of the Czech Republic (grant MSM 111600001).
Lack of Evidence of Relationship Between Helicobacter Pylori Infection and Ato-
pic Dermatitis in Children
C. Guerriero, A. Carbone, J.M. Nowak, and G. Fabrizi
Pediatric Dermatology, Catholic University of Sacred Heart, Roma, Italy
There is increasing evidence for systemic e¡ects of gastric Helicobacter pylori (HP) infection which
may result in extragastrointestinal disorders. Based on a number of reports a possible relationship of
HP infection to a variety of di¡erent dermatoses has been suggested, including urticaria, rosacea, alo-
pecia areata, Sjogren’s syndrome, Schonlein-Henoch purpura and atopic dermatitis, but the data are
still con£icting. In particular a positive association between HP antibodies and atopic dermatitis
(AD) as the sole manifestation of food allergy has been reported. This study was designed to deter-
mine whether a signi¢cant association between AD and HP infection could be found in pediatric
patients. Thirty-three patients (age range, 7-12 years) a¡ected by moderate to severe AD as de¢ned
according to the criteria of Hani¢n and Rajka and 29 age- and- sex matched healthy controls were
tested for HP infection with the urea breath test using urea labeled with carbon 13 (13C). Among the
patients with AD only one had a positive C-urea breath test result while 32 had a negative result.
Among the 29 healthy controls 5 had a positive C-urea breath test result and 24 had a negative result.
Our data show that in our patients the prevalence of HP infection in children with AD is low and it is
comparable with that observed in the healthy controls. In conclusion there is a lack of evidence of a
relationship between HP infection and AD in children.
Association of Food Allergy with Interleukin 4 Receptor Alpha Chain Polymorph-
ism Gln551Arg of Atopic Dermatitis in Korea
H. Park1,Y.K. Seo2, S. Lee3, and G. Noh1*
1Dept. of Allergy & Clinical Immunology, Seoul Allergy Clinic, Seoul, Korea, 2Dept. of Molecular Immunology,
Seoul Allergy Institute, Seoul, Korea, 3Dept. of Food & Nutrition, College of Ecology, Hanyang Univ, Seoul, Korea
Atopic dermatitis (AD) is an allergic in£ammatory skin disease, which results from the interaction
between genetic and environmental factors. Several candidate genes for atopic dermatitis including
human interleukin 4 receptor alpha (hIL-4Ra) chain has been proposed. A variant of hIL-4Rawith
arginine at amino acid 551, instead of glutamine, has been reported to be correlated with hyper IgE
syndrome and severe atopic eczema. Hereby, hIL-4Ra Gln551Arg polymorphism was investigated in
33 AD patients (mean 7.9 years of age, 1/12 - 35) and 8 healthy volunteers (mean 27.5 years of age, 24 ^
33) as normal controls. Double-blind placebo-controlled food challenge (DBPCFC) were performed
for several foods. Among 53 AD patients, 26 (49.1%) were heterozygous for the Arg551 allele (Gln/
Arg), one (1.8%) was homozygous as Arg/Arg, and 26 (49.1%) were homozygous as Gln/Gln, but this
allele did not occur in all normal controls. Between Gln/Gln atopic dermatitis and Gln/Arg AD, there
were no laboratory di¡erences in blood total IgE levels, eosinophil fractions toWBC, and total eosi-
nophil counts. Interestingly, 56.3% (9/16) of AD with Gln/Arg heterozygous genotype showed allergy
to egg comparing with 33.3 % (4/12) with Gln/Gln homozygous genotype. In contrast, 57.1% (8/14) of
AD with Gln/Gln homozygous genotype showed allergy to milk comparing with 23/1% (3/13) with
Gln/Arg and 66.7% (6/9) with Gln/Gln showed allergy to soyabean comparing with 23.1% (3/13) with
Gln/Arg. Prevalence of allergy to wheat was similar in both Gln/Gln homozygous genotype and Gln/
Arg heterozygous genotype. In our study, none of normal healthy controls showed a hIL-4Ra chain
variant. The frequency of hIL-4Ra Gln551Arg polymorphism was much higher in Korea than those
of previous reports. hIL-4RaGln551Arg polymorphism seemed to be related with the causative foods
in atopic dermatitis. hIL-rRa Gln551Arg polymorphism might be possible as an important indicator
for the classi¢cation of atopic dermatitis as subtypes and further study will be needed.
A Comparison Study of the Staphylococcal Exotoxins and Staphylococcal Entero-
toxin A-Speci¢c IgE Antibody Between Childhood and Adulthood Atopic Derma-
titis
C.W. Park, H.W. Kim, and C.H. Lee
Department of Dermatology, college of Medicine, Hallym University, Seoul, Korea
The skin of patients with atopic dermatitis (AD) exhibits a striking susceptibility to colonization with
Staphylococcus aureus (S. aureus). Superantigens produced by S. aureus and their speci¢c IgE antibodies
are thought to be important precipitating factors of AD, but there are few reports evaluating these 2
factors at the same time, particularly in adulthood AD patients. This study was done to investigate the
di¡erences in the culture degree of S. aureus from the lesion, non-lesion, and control group of child-
hood and adulthood AD patients, to research the correlation between the exotoxin production, total
IgE, anti-SEA IgE and the disease severity by SCORAD index, to ascertain the di¡erences between
childhood AD patients and adulthood AD patients. S. aureus colonizations were found in 11 (36.7%)
of the lesional skin, in 5 (16.7%) of the non-lesional skin of 30 childhood AD patients, and in 26
(86.7%), in 20 (66.7%) of 30 adulthood AD patients, respectively. The colonization rates of S. aureus,
36.7% of lesional skin and 16.7% of non-lesional skin in childhood patients were much lower than
those in adulthood patients, 86.7% of lesional skin and 66.7% of non-lesional skin. Staphylococcal
exotoxins were detected in 5 (45.5%) of the 11 colonizations from lesional skin, in 2 (40%) of the 5
colonizations from non-lesional skin of children, and in 10 (38.5%) of the 26 colonizations, in 9 (45%)
of the 20 colonizations of adults, respectively. SEA was most frequently detected in both groups. S.
aureus colonization was correlated with the severity of AD in childhood, but not in adulthood. How-
ever, there were no statistical signi¢cances between severity of AD and others such as exotoxin pro-
duction, and the level of total IgE and anti-SEA IgE in both groups. In conclusion, the colonization
of S. aureus was more common in adulthood AD patients than childhood AD patients. Anti-SEA IgE
level was much higher in adulthood AD patients than in childhood AD patients. It is tempting to
speculate that the colonization of S. aureus and exotoxin production might be related to the disease
duration rather than clinical severity of AD.
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Atopic Dermatitis and Food Allergy: Diagnostic Role of SPTs and DBPCFC in 62
Children
L. Brunetti, P. Fiermonte, R. Francavilla, M. Leone, R.Tesse, C. Massagli,V. De Sario, F. Mastronardi, F.
Fiore, and L. Armenio
Department of Pediatrics, University of Bari, Italy
Background: Food allergy (FA) plays an important role in the pathogenesis of atopic dermatitis (AD),
indeed it a¡ects about one-third of the children with AD in the ¢rst few years of life. Immediate-type
clinical reactions to food can be identi¢ed by clinical history, skin prick tests (SPTs), measurement of
speci¢c IgE and oral food challenges.
The aims of the study were to evaluate: a) the role of FA in children with AD and b) the relation-
ship between early-phase and/or late-phase reactions in double-blind, placebo-controlled food chal-
lenges (DBPCFC) and SPTs positivity.
Methods: 62 consecutive children [38 males; median age 2.2 (range 6 mo ^ 13 yrs)] with severe AD were
included in the study. All patients performed SPTs (prick test and prick by prick with fresh food) and
then were maintained on an exclusion diet for 4 weeks. Children who presented a reduction of the
SCORAD of at least 1/3 were de¢ned as responders and underwent the DBPCFC with the food
identi¢ed by SPTor with that suspected by the clinical history.
Results: 42 patients (67.8%) completed the trial. In the 34 responders, SPTs were positive to cow’s milk,
hen’s egg, potato, wheat, carrot and veal. Of the 63 oral challenges, 21 (33.3%) were positive and 42
(66.7%) negative. Amongst 6 (28.6%) positive and in 8 (19%) negative challenges both SPT and
DBPCFC were positive; amongst 15 (71.4%) positive and in 28 (66.7%) negative challenges, both
prick by prick with fresh food and DBPCFC were positive. These di¡erent diagnostic tests allow us
to identify the most commonly o¡ending foods in AD: cow’s milk (42.9%), hen’s egg (19 %), wheat
(19%), potato (9.5%), carrot (4.8%) and veal (4.8%). The 62% of children with positive challenges
showed early clinical reactions (urticaria, worsening of eczema with erythema and itch, wheezing),
the 28% showed late reactions (exacerbation of eczema and itch) and 10% combined early and late
clinical reactions.
Conclusions: The study suggests that SPTs, although helpful in the diagnostic work-up for FA, cannot
substitute the DBPCFC that remains the gold standard for its diagnosis in children with AD because
its negativity helps to prevent unnecessary restrictive diets.
Role of Foods in Irregular Aggravation of Atopic Dermatitis in Japan
T. Uenishi, H. Sugiura, and M. Uehara
Department of Dermatology, Shiga University of Medical Science, Otsu, Japan
Background: Although it is well known that patients with atopic dermatitis often show irregular aggra-
vation of skin lesions, it remains to be determined what factors could cause the irregular worsening of
the disease. In the present study, we investigated whether foods play a role in the irregular exacerba-
tion of skin lesions in adult patients with the disease in Japan.
Method: The study population consisted of 195 adult patients with atopic dermatitis who showed irre-
gular aggravation of skin lesions. They were asked to keep a diary of foods and skin conditions for 2
months.We then chose food items which were eaten, not every day, but on the day or the preceding
day of the irregular exacerbation. Elimination and open challenge tests with suspect foods were per-
formed. Challenge-positive foods were determined by evaluating comparable before-after challenge
photographs. When possible, speci¢c IgE antibodies to the o¡ending foods were measured by the
radioallergosorbent test (RAST). We then observed the skin condition for 3 months during which
patients were prohibited from eating the o¡ending foods.
Results: Challenge-positive foods were con¢rmed in 86 (44%) of the 195 patients examined. Predomi-
nant o¡ending foods were chocolate, cheese, co¡ee, yogurt and some Japanese foods such as glutinous
rice cake, soy sauce and fermented soy beans. Positive RAST reactions to the o¡ending foods were
rare. Exclusion of the o¡ending foods brought about a progressive improvement of the disease.
Conclusion: Foods play an important role in irregular aggravation of skin lesions in adult patients with
atopic dermatitis.
The Use of Atopy Patch TestsWith Aeroallergens in Diagnosis of Atopic Dermatitis
in Children
M.Wanat-Krzak, R. Kurzawa, and K. Pisiewicz
Department of Allergology and Pneumonology, National Institute ofTuberculosis and Lung Diseases, Rabka-Zdro¤ j,
Poland
Atopic dermatitis is a multifactorial, chronically relapsing skin disease. It has been demonstrated that
food allergens are most important environmental antigens early in life. In older children the aeroaller-
gens plays an important role. In this study the outcomes of atopy patch tests with aeroallergens in
three groups of children were compared; group I- children with atopic dermatitis and negative skin
prick tests, group II ^ children with atopic dermatitis and positive skin prick tests, group III - with
atopic dermatitis, positive skin prick tests and allergic diseases of the respiratory tract. Tests were done
in 39 children and 20 (51%) of them had positive outcome. The control group consist of 12 children
with allergic diseases of the respiratory tract and positive skin prick tests without atopic dermatitis. In
this group only 2 children had positive outcome of atopy patch tests. The outcomes and atopy patch
tests in whole group of children with atopic dermatitis were compared. 18.6% of children with atopic
dermatitis had positive outcome of skin prick tests, and 14.1% of them had positive outcome of atopy
patch tests. It seems that atopy patch tests are as useful as skin prick tests in diagnosis of atopic derma-
titis.
Patch Testing with Egg Represents a Useful Integration to Diagnosis of Egg
Allergy in Adolescents and Adults with Atopic Dermatitis
F. Giusti, and S. Seidenari
Department of Dermatology, University of Modena and Reggio Emilia, Italy
Food atopy patch tests are considered a useful tool for the diagnosis of food allergy in patients with
atopic dermatitis. Hypersensitivity to eggs has been investigated by means of atopy patch tests only in
infants and children, so far. Our aimwas to investigate atopy patch test and skin prick test responses to
egg in adolescents and adults with atopic dermatitis, and to evaluate the relevance of these results by
performing repeated open challenges with egg. Atopy patch tests and skin prick tests with egg were
performed in 58 atopic dermatitis patients, aged from 16 to 47 years, employing egg yolk and white
separately. All subjects underwent repeated open challenges with egg. 17.2% of our patients reacted to
the challenge. Positive responses to atopy patch tests were recorded in 18.9% of the patients, whereas in
12.1% positive skin prick tests were observed. Atopy patch test sensitivity and positive predictive value
proved signi¢cantly higher than skin prick test’s. Our data suggest that atopy patch tests with eggs
may represent a useful tool in the diagnostic work-up of food allergy in atopic dermatitis patients.
Patch Testing in Children with Atopic Dermatitis
A. Belloni Fortina, F. Marciani Magno, I. Romano, M.T. Corradin, G.P. Recchia, F. Larese, F. Scardigli,
C. Carriere, and S. Piaserico
North East Italy Contact Dermatitis Group (NEI-CDG), Padova, Italy
Background and aims: Recent studies have demonstrated that contact sensitization in children is not un-
common, being more frequent than previously thought. However, con£icting data have been re-
ported on the di¡erence in patch test reactivity between children with or without atopic dermatitis
(AD).
Methods: We have studied the patterns of response to patch testing in 238 children (r16 years) with
atopic dermatitis (130 females, mean age 9.0574.2) and with suspected allergic contact dermatitis
(ACD) and compared the results with a control group of 119 children with mucosal atopic diseases
and with suspected ACD (67 females, mean age 10.973.9) and a group of 348 children with ACD
but without any personal history of atopic diseases (236 females, mean age 10.274.4).
Results: The prevalence of positive patch test to at least one hapten was similar in the group of children
with atopic dermatitis and in both control groups (50.8% vs 47.1% and 50.8% in patients with AD
and ACD, mucosal atopy and ACD and only ACD, respectively) and only few allergens showed a
statistically signi¢cant di¡erence in the sensitization rate among children with AD compared with
children without AD when evaluated with age-adjusted logistic regression. The most frequent contact
allergens in children with atopic dermatitis were nickel (12.6%), potassium dichromate (8.1%), lanolin
(6.3%), perfumes (5.8%), disperse blue (4.2%), neomycin (3.4%), and kathon CG (3.4%).
Conclusions: These ¢ndings suggest a similar reactivity to delayed hypersensitivity allergens among
children with suspected ACD with or without AD and support the use of routine patch testing in
children with AD.
Is Immunophenotyping Useful in Diagnosis of Atopic Dermatitis Diagnosis?
J. Lipozenc› icŁ ,
J. JakicŁ RazumovicŁ , S. LjubojevicŁ , and D. Bobek
Department of Dermatology andVenerology and Department of Pathology Zagreb University Hospital Center,
S alata 4, Zagreb, Croatia
Introduction: There are many in vitro and in vivo diagnostic tools to perform immunological dysfunc-
tion in the pathogenesis of atopic dermatitis (AD). Immunophenotyping of in£ammatory cell surface
markers in the biopsies of AD lesions was made.
Methods: To perform the presence of in£ammatory cell surface markers in the biopsies of skin lesions
we performed immunohistochemical analysis in 15 AD patients and 5 healthy subjects. Standard avi-
din-biotin immunoperoxidase staining of paraphin-embadded, 4 mm skin sections with semiquantita-
tive counting of cells labeled with anti-CD3, anti CD8, anti CD20, anti-HLA DR (HLA human
leukocyte antigen), and anti -immunoglobulin E (anti-IgE) primary antibodies, was done.
Results: The results of our study showed that CD4þ prevail over CD8þ in the in¢ltrate of AD skin
lesions. In comparison with normal skin, a higher expression of HLA DR on dermal lymphocytes
and epidermal LCs and IgEþ cells were found. The in¢ltrating cells expressing CD3, CD4 and
HLA-DR cell-surface markers in the dermis and epidermis, CD8 in the dermis and IgEþ cells in
the epidermis.
Conclusion: Immunohistochemistry has recently become a recognized and necessary part of pathodiag-
nosis in dermatopathology. The comparison of the AD patient group and the control group of healthy
subjects showed that the two groups di¡ered in the number of in¢ltrating cells expressing CD3, CD4
and HLA-DR cell surface markers in the dermis and epidermis, CD8 in the dermis and IgEþ cells in
the epidermis.
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Long Term Follow-Up in 205 Children with Atopic Dermatitis. Preliminary Data
A. Patrizi, G. Ricci, L. Pagliara, M. Albertini, G. Menna, and M. Masi
Clinical and Experimental Medicine-Division of Dermatology, Department of Pediatrics University of Bologna,
Italy
We studied 205 children (104 boys and 101 girls) with atopic dermatitis (AD), whose diagnosis was
made on the basis of Hani¢n and Rajka’s criteria. The children were 3^36 months of age at the time
of the ¢rst examination; the evaluation of the severity of the disease was made using the Rajka and
Lageland clinical score considering the intensity, extent, and course of lesions. Patients with a total
score of 3^4 were considered to have mild AD, 5^7 moderate AD, 8^9 severe AD. After a mean period
of 17.5 years an interview by a questionnaire was performed. AD completely disappeared in 124 cases
(60.5%) while it remained in 81 cases (39.5%) with di¡ering scores of severity. The severity of the
disease at the time of ¢rst observation was not associated with the di¡erent outcome follow up regard-
ing AD: in the 67 children with mild disease, AD persisted in 23 cases (34%), in the 99 children with
moderate form it persisted in 43 cases (43%); in the 39 children with severe form, in 15 cases(38%).
Family history of atopy and high IgE level at the ¢rst observations were not related to the disappear-
ance of AD. Rhinoconjunctivitis (RC) appeared in 116 cases (56%), asthma (A) in 67 cases (32%) and
oral allergic syndrome (OAS) in 59 cases (29%). The appearance of A was statistically signi¢cant
(po0.001) and higher in the group with severe AD at ¢rst observation (56% of cases) than in moder-
ate (24%) or mild (31%); RC and OAS were observed with similar percentages in the 3 groups of
severity. OAS was signi¢cantly (Po0.01) associated with persistent AD (32 cases:40%) than in the
group where disappeared (27 cases:22%), while the persistence of AD was associated with a slight
but not signi¢cant increase in RC (65% vs 51%) and A (37% vs 30%).
Multidiscplinary Approach to Atopic Dermitis in Children: a Single Center Ex-
perience at Bambino GesuØ Children’s Hospital
M. El Hachem, G. Biondi, S. Bottero, R. Cutrera, A. Diociaiuti, F. Ferretti, L.
Giraldi, C. Paone, and G. Castelli Gattinara
UnitaØ Operativa di Dermatologia;
Servizio Psico-sociale; UnitaØ Operativa di Otorinolaringoiatria;UnitaØ Operativa di Broncopneumologia;
UnitaØ Operativa di Gastoenterologia;
UnitaØ
Operativa Immunoinfettivologia ^ AIDS, Ospedale Pediatrico Bambino GesuØ , Roma, Italy
Atopic dermatitis is a cutaneous manifestation of atopy, that is well known to predispose to the onset
of allergic manifestations by many organs. This disease is very di⁄cult to treat due to several problems:
chronic-recurrency, severe itching, unaesthetic appearance, psychological problems. For these reasons
the Dermatology Unit of our Hospital started, since September 2001, a multidisciplinary approach to
atopic dermatitis involving specialists in Allergology, Broncopneumology, Dermatology, Gastroenter-
ology, Infectious Diseases, Otorhinolaryngology and Psychology. Our young patients also undergo, if
required, haematological examinations, prick tests, patch test and topical treatment under the guidance
of our nurses who, shaming a play for the children, teach the parents how to treat their children. Later,
parents have to demonstrate to be able to make treatments on their own. Sixty consecutive children
were included in the evaluation of the multidisciplinary approach. Patients’ mean age was 27.71
months, 64% of them had associated allergic diseases of organs other than the skin (asthma, rhinitis,
gastrointestinal symptoms and otorrhea). 26% of the patients su¡ered from psychological insomnia
and hyper-excitability. At the end of the treatment 84% of the patients presented clinical improve-
ment, 7% was unchanged, and 9% had clinical worsening. The high incidence of extra-cutaneous
manifestations and the psychological problems underlie the importance of co-ordinated approach to
the treatment of atopic dermatitis. In conclusion, our experience suggests that the child a¡ected by
atopic dermatitis has to be treated with a professional multi-specialised approach with the collabora-
tion of several specialists and nurses. Moreover, parents should be guided and supported in order to
better face a chronic disease, that could create discomfort to the child and the entire family.
Speci¢c Allergy Vaccination in Atopic Dermatitis
E.S. Fedenko, and N.I. Ilina
Institute of Immunology, Moscow, Russia
Allergen-speci¢c immunotherapy (ASIT) is based on the administration of gradually increasing doses
of allergen extracts to allergic patient. ASIT has been widely used to treat allergic rhinitis and allergic
asthma. At the same time there is not enough evidence of therapeutic e⁄cacy of ASIT in atopic der-
matitis (AD). The aim of the study was to evaluate the e⁄cacy of ASIT in AD patients.
Materials and methods: 165 AD patients were included it this study. All of them had symptoms of AD
and respiratory allergy: allergic rhinitis and/or allergic asthma. All the patients received ASIT with
HDM and pollen allergen extracts after clinical improvement of AD symptoms had been achieved
by means of topical steroids and H1 blockers. During ASIT itching and skin irritation were observed
in 63% of patients, but none of them dropped out during the study. Clinical e⁄cacy and safety were
evaluated.
Results: ASIT appeared to be e⁄cacious in 83% of AD patients in spite of slight skin exacerbation
which did not need any special treatment. We observed the improvement of skin and respiratory
symptoms, reduction of needed medications.
Breast-feeding and Atopic Dermatitis in Infants
I. Sokolovski
Public Health Organisation, Moscow, Russia
Background: Infancy is a specially vulnerable period in which infants are in increased risk of becoming
sensitised to food and other allergens. Atopic dermatitis (AD) occurs with high incidence in period of
infancy. 60% of a¡ected individuals manifest AD during the ¢rst year of life. Human milk (HM)
provides passive and likely long-lasting active immunity. Thus the protective immune factors in HM
and delayed interduction of cows milk and solid food are possible preventive e¡ect in appearance of
AD.The aim of the study is to con¢rm the important role of exclusive breast-feeding (BF) in preven-
tion of AD at infants.
Methods: Total of 468 infants born during the period of 01.01.96 to 31.12.01 year were including in the
study. First group of 300 (62.4%) infants were long term exclusively six mounts BF infants with solid
food avoidance in this period. Second group of 168 (37.6%) infants were short time 1^2 mounts or not
at all BF infants complementary feeding with cows milk formula (CMF).
Results: In the ¢rst group of 300 exclusively BF infants only 11 (7 male and 4 female) infants developed
AD (3.4%). In the second group of 158 infants feeding with traditional CMF 31 (19 male and 12 fe-
male) infants develpoped AD (18.2%) in the ¢rst year of life.
Conclusions: The study present the favorable results of exclusively BF and it is recommended as a pre-
ventive measure for the development of AD in period of infancy. Due to fact that AD is the ¢rst
manifestation of atopic diseases in childhood this primary prevention of AD may have long term
positive consequence for decreasing risk of this diseases.
Clinical Study on the Signi¢cance and the Frequency of Atopic Dermatitis in
Nummular Eczema
S.H. Cho, J.-W. Kim, C.-W. Park, and Y.-S. Ro
The Catholic University of Korea; Hallym University Medical College; Hanyang University Hospital, Korea
Nummular eczema has been reported to be one of the minor clinical manifestation of atopic derma-
titis. The frequency of nummular eczema in atopic dermatitis patients has been reported to be about
16.9% compared to 1.0% in normal population of Korean. But there was no previous literature eval-
uated the frequency of atopic dermatitis in nummular eczema patients in Korea. The aim of this study
was to evaluate the frequency of atopic dermatitis in nummular eczema patients and to help the treat-
ment and the prevention of nummular eczema patients. A total of 49 patients who had visited Depart-
ment of Dermatology, Our Lady of Mercy Hospital, from January 1995 to December 2002, were
diagnosed as nummular eczema with clinical and histopathological ¢ndings. The retrospective analysis
of medical records, photographs, and biosy specimen was performed. The results are summarized as
follows: (a) The number of patients with atopic dermatitis was 18 (36.7%) and non-atopic dermatitis
was 31 (63.7%); (b) The mean age of patients with atopic dermatitis was 18.8 years and non-atopic
dermatitis was 41.7 years; (c) The mean onset age with atopic dermatitis was 16.7 years and non-atopic
dermatitis was 39.7 years; (d) Other minor clinical features of atopic dermatitis in nummular eczema
patients were anterior neck folds, xerosis, super¢cial folliculitis, keratosis pilaris, recurrent herpes sim-
plex, white dermographism, cheilitis, Dennie-Morgan infraorbital fold, orbital darkening, and pityr-
iasis alba in the order of frequency; (e) The mean IgE level with atopic dermatitis was 856.9 ng/ml and
non-atopic dermatitis was 150.1 ng/ml; and, (f) The mean eosinophil count with atopic dermatitis was
271.1/mm3 and non-atopic dermatitis was 130.5/mm3. This data shows that nummular eczema was fre-
quently associated with atopic dermatitis. The onset age of nummular eczema was younger in patients
with atopic dermatitis than in non-atopic dermatitis.We suggest that while caring the nummular ec-
zema patients, dermatologist should consider that atopic dermatitis may be frequently combined with
nummular eczema. Additional supportive managements such as avoidance environmental factor, food
allergy, irritant allergy, infection factor, and so on, might be helpful in the treatment of nummular
eczema patients.
Nummular Eczema in Childhood: a Retrospective Study of 245 Cases
A. Patrizi, F. Specchia, S. Marzaduri, M. Medri, B. Bendandi, and G. Ricci
Clinical and Experimental Medicine-Division of Dermatology, Department of Pediatrics University of Bologna,
Italy
Nummular eczema is characterized by a typical morphological appearance. Usually an acute eruption
of a well-demarcated coin-shaped lesion, 1^5 cm in diameter, is observed. Lesions more than 10 cm in
diameter are seldom seen. It was described for the ¢rst time by Devergia in 1857 and its lesions are the
result of the con£uence and peripheral extension of minute vescicles and papules. In the acute phase
the lesions consist of erythematous patches associated with severe itching which results in loss of sleep
and restlessness. These patches are more often located on the extensor surfaces of the limbs and on the
face, but also the trunk can be involved. In a ¢ve year period between 1997 and 2002, 2830 out pa-
tients a¡ected by eczema were referred to the pediatric department of our dermatology clinic. 245 of
these (8.6% of the patients with eczema), presented the clinical appearance of nummular eczema. In 18
patients only one lesion was present, while in the other 227 patients lesions were multiple. The patients
consisted of 153 males (65%) and 92 females (35%). In our patients the onset of clinical manifestations
was between 40 days of life and 12 years, 200 of whom showed a higher prevalence in the ¢rst 2 years
of life. In 57 of our cases an adequate follow-up was not possible. In the other 188 patients, 136 children
(72.3%) were a¡ected by atopic dermatitis, 7 had a contact dermatitis and in 45 cases etiology could
not be established.
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Keratoconus and Atopic Dermatitis: a Puzzling Problem
C. Gelmetti, and C. Colonna
Institute of Dermatologic Sciences, University of Milan, I.R..C.C.S.‘‘Ospedale Maggiore’’, Milan, Italy
Keratoconus (K) is a disease characterized by thinning and ectasia of the central cornea. The associa-
tion with atopy has been reported on several occasions. In a study of 182 cases of K a history of atopy
was found in 35% compared with 12% in the controls. The serum IgE was signi¢cantly raised in K
and markedly so in atopic patients [1]. In 162 K patients, the prevalence of asthma was from 0.4% to
1% in the control group to 17.9% in the K group and the incidence of hay fever in K patients was
found to be 35.7% [2]. However in a study on 2723 patients, atopy was not statistically related to out-
come of K [3] and in 240 cases of atopic dermatitis Kwas detected only in 1.3%, of cases [4] or con-
sidered non speci¢c [5]. In addition, a recent study suggests that the most signi¢cant cause of K is eye
rubbing, while atopy may contribute probably via eye rubbing associated with the itch [6]. Di¡erent
hypothesis state that there is abnormal processing of the free radicals and superoxides within the K
corneas [7]. Indeed in K, corneal levels of extracellular superoxide dismutase were half those in the
controls [8] and K corneas showed evidence of oxidative damage from cytotoxic byproducts generated
by lipid peroxidation and the nitric oxide pathway [9] suggesting that K corneas do not process reac-
tive oxygen species normally, which may play a major role. This fact could explain success of antiox-
idant treatment (selenomethionine and vitamin E) in those patients [10].
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Marginal Vesiculopustular Band of the Sole Occured in Remission Phase of Severe
Atopic Dermatitis
K. Isoda,Y. Imai, S. Shima, R. Hitaka,T. Murakami, and H. Mizutani
Department of Dermatology, Mie University, Faculty of Medicine,Tsu, Japan
Atopic dermatitis (AD) is characterized by the typical morphology and distribution. In adults, the
eruption involves the classic antecubital and popliteal fossae, the front sides of the neck, the forehead,
and the area around eyes. Flares of atopic dermatitis are commonly triggered by exposure to antigens,
acute infection and emotional upsets, and result in the wide spread type of involvement. The intensive
therapies with topical corticosteroid and systemic anti-allergic drugs control the skin lesions around a
week later. In contrast to the improved skin lesions, newly developed vesiculopustular lesions distrib-
uted along the margin of the sole, especially median side. A biopsy specimen revealed an intraepider-
mal large spongiotic vesicle with neutrophil and eosinophil in¢ltration.These lesions were commonly
observed in the AD cases with systemic £are up (5 of 5 cases with systemic exacerbation), but not in
the less involved milder cases. The pathogenesis of these lesions are obscure now. Around 30% of the
atopic individuals have ichthyosis. The margin of the sole is a transit zone from the hypohidrotic to
hyperhidrotic skin. Dyshidrosis may be involved the pathogenesis of these lesions.
Lichen Amyloidosis Associated with Atopic Dermatitis
I. Neri, A. Patrizi, B. Raone, and M. Medri
Clinical and Experimental Medicine-Division of Dermatology, University of Bologna, Italy
A 40-year-old man, father of an 8-year-old girl a¡ected by atopic dermatitis (AD) since the age of 6
months, referred to us for papular pruriginous lesions. The father had su¡ered from AD since early
childhood and from allergic asthma since the age of 8 years. Clinical examination revealed tiny,
dome-shaped papules on the licheni¢ed skin of the pretibial regions and the antecubital fossae of both
legs. Crops of similar papules were found on the back, shoulders and buttocks. Two biopsies of pa-
pules were performed and histology showed hyperkeratosis and acanthosis of the epidermis and de-
posits of amyloid in the papillary dermis. A diagnosis of lichen amyloidosis (LA) was made. Family
history revealed that the man’s father had su¡ered from systemic amyloidosis with cardiac involvement
secondary to multiple myeloma without cutaneous involvement since the age of 63. One year after he
had died of cardiac shock. No other members of the family were a¡ected by systemic or cutaneous
amyloidosis. Association between LA and concomitant atopic respiratory diseases has been previously
reported in the literature and recently a case of LA associated with AD has been described. An association
between persistent scratching and genetic factors has been proposed in the etiology of cutaneous amyloi-
dosis. The presence of a member a¡ected by systemic amyloidosis and of another with LA and atopy is a
very particular association never reported in the literature, to the best of our knowledge.
Nocturnal Itch and Sleep Disturbance of Atopic Dermatitis
T. Ebata
Department of Dermatology, Jikei University Daisan Hospital,Tokyo, Japan
Itching is the major symptom of atopic dermatitis (AD) and the resultant scratching apparently wor-
sens the skin lesion. It is known that itch worsens and the patients scratch severely during the night.
We have been measuring nocturnal scratching of AD patients using an infrared video camera (Br J
Dermatol 141:82^6, 1999) and a wrist activity monitor (Br J Dermatol 144:305^9, 2001). Scratching time
(total duration of time spent in scratching) correlated well with the severity of the disease, and de-
creased in response to the treatment of AD. The video recordings gave the physicians true images of
how severely patients scratch during the night. Itch interferes with sleep in patients with severe AD.To
investigate further the details of sleep disturbances in AD, we recorded polysomnography (PSG) in 6
adult patients of varying severity. In one patient with mild AD, almost normal sleep both in quality
and quantity was observed, while in the patients with moderate and severe AD sleep was disturbed
according to the severity. Sleep e⁄ciency was reduced to 50 to 70% of normal in these groups.
Scratching was less frequent in deep stages of sleep. The PSG study showed that sleep was disturbed
in proportion to the clinical severity of AD. Scratching took place mostly in the early hours of the
night. The triggering factor of itch during this period should be sought for better sleep and better
control of AD.
Atopic Dermatisis: How Does it A¡ect the Family?
E. Andreoli,V. Antinone, E.D. Finore, A. Provini, M. Paradisi, and P.G. Foglio Bonda
Istituto Dermopatico dell’Immacolata, IRCCS, Roma, Italy
Atopic Dermatitis (AD), for its characteristics - early onset, chronic and recurrent course, rising pre-
valence- remarkably in£uences the life quality of Italian families within many contexts, among which
the economic one. The group sample of this study is made of 100 subjects, males and females, hospi-
talized with an AD diagnosis, subdivided by age di¡erentiation in two groups of 50 subjects (1^6;
7^12 yrs old); and their related families. Objectives of our study were (a) to evaluate the AD impact,
as a chronic disease, on the patient’s family; (b) to observe in patients and in their families common
behaviors and/or characteristics; and (c) to identify the economic expense of the disease and its
‘‘weight’’ on the family budget. The methods used were a Parents Questionnaire, to detect the family’s
most signi¢cant behaviors and psychological characteristics; an Expenses Questionnaire, to identify
the economic expense of the disease, subdivided in monthly amount, annual amount and singular
purchase; and the SCORAD index, for a standardized evaluation of the AD severity.We display the
related outcome data, underlining how dysphoric feelings observed in parents interfere with the med-
ical prescription compliance and how the disease expenses do not appear to be directly correlated with
the gravity of the dermopathy, but with other elements, particularly with those dysphoric feelings.
A Study to Determine the Short-Term E⁄cacy of Wet Wrap Dressings as a Treat-
ment for Moderately Severe Atopic Eczema in Children
L.-A. Murphy
St Johns Institute of Dermatology, London, UK
Background: The wet wrap dressing technique was developed and has been progressively modi¢ed at
Great Ormond Street Childrens Hospital NHS Trust, London. It is an e¡ective means of controlling
more severe or generalised atopic eczema which has failed to be controlled with a simpler regime and
can be a valuable adjuvant therapy.
Objective: To establish superior short-term e⁄cacy & safety of wet wrap dressings applied over a mild
topical corticosteroid in moderate-severe childhood atopic eczema compared either to the same topical
corticosteroid alone or to identical wet wrap dressings applied over emollient alone.
Methods: Children whose eczema could be objectively characterised as moderately severe or severe were
recruited from the outpatient department and ward admissions. All patients had failed to respond
adequately to standard topical therapy with emollients, weak topical corticosteroid and oral anti-his-
tamines. Patients treated with oral or inhaled corticosteroid or systemic antibiotic in the preceding
week were required to complete a one-week run in period before entry into the trial. They were
randomised to receive treatment with wet-wrap dressings & emollient, wet wrap dressings with topi-
cal corticosteroid or topical corticosteroid alone. Response to reatment was assessed using 2 validated
scoring systems (SASSAD, GOS score), haematological, biochemical and immunological assays. Asess-
ments were conducted one week apart by a single blinded investigator.
Results: 37 patients (14m, 23f; mean age 7.2 yrs, range 3^15 yrs) were randomised to one of 3 treatment
limbs. Individuals treated with wet wraps & corticosteroid enjoyed a substantially better & clinically
valuable therapeutic response when compared to either of the other 2 groups. There was no evidence
of haematological, renal or hepatic toxicity in any of the 3 groups.
Conclusion: Treatment for 1 week with wet wrap dressings and topical corticosteroid gave signi¢cant
improvements in eczema scores, when compared to treatment with either topical corticosteroid alone
or wet wrap dressings & emollient. Children found wet wrap dressings acceptable whilst their parents
considered them a worthwhile treatment. The advent of wet wrap dressings as a treatment for atopic
eczema in children has provided a substantial improvement in the provision of short-term relief of
symptoms. It is the authors opinion that this treatment is frequently underused.
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E⁄cacy of 0.03% Tacrolimus Ointment in Patients With Atopic Dermatitis of the
Head and Neck
K.-B. Suhr,Y.-S. Kim, J.-S. Yoon, E.-J. Lee, K.-C. Kye, J.-H. Lee, and J.-K. Park
Department of Dermatology, Chungnam National University, College of Medicine, CNU Dermatologic Clinic
Daejeon, Korea
Atopic dermatitis (AD) is an in£ammatory skin disease with chronically relapsing course. Tacrolimus
(FK506) is a novel immunomodulatory agent exerting its e¡ects by acting on the signal transduction
pathways inside T cells and inhibiting gene transcription. Unlike topical corticosteroids, tacrolimus
ointment doses not cause skin atropy.We studied the open clinical e⁄cacy of tacrolimus for patients
with AD of the head and neck. Twelve patients with atopic dermatitis of the face and neck applied
with tacrolimus ointment 2 times a day. Treatment e⁄cacy was evaluated using the average subjective
satisfaction scores for each symptom and the global clinical response. In addition, the SCORAD
(Scoring AD) index of the head and neck was adopted to evaluate the severity of AD as objectively
as possible. Most of patients (10 of 12 patients) had remarkably improved when applying with tacroli-
mus objectively or subjectively. Signi¢cant e¡ects were observed after 1 week of application with ta-
crolimus. The side e¡ects such as burning (50%) or itching sensation (50%) were developed, but well
tolerated to continue the study. Conclusively, the topical application of tacrolimus is an e¡ective regi-
men for the treatment of atopic dermatitis of the head and neck.
Insight into Genetics of Atopic Dermatitis: Future Approaches and Directions
G. Novelli1, E. Giardina1, M. Paradisi2, C. Pedicelli2, G. Girolomoni3, F. Nasorri3, S. Chimenti4, G.
Marulli4, P. Rossi5,V. Moschese5, L. Chini5, and F. Capon16
1Dept. of Biopathology,TorVergata University of Rome, Italy; 2Div. of Pediatric Dermatology, and 3Lab. of
Immunology and Second Div. of Dermatology, Istituto Dermopatico dell’Immacolata, IRCCS, Rome, Italy; 4Dept.
of Dermatology,TorVergata University, Rome, Italy; 5Div. of Immunology and Infectious Disease, Dept. of
Pediatrics, Children’s Hospital ‘Bambino Gesu’and Dept. of Pediatrics,TorVergata University of Rome, Italy; 6Div.
of Medical Genetics, University of Leicester, UK
Atopic dermatitis (AD) is a chronic in¢ammatory skin disease typi¢ed by itchy in£amed skin, asso-
ciated with cutaneous erythema and severe pruritus and characterized by an onset mainly in early
childhood. In developed countries the prevalence of AD is approximately 15%, with a strong increase
during the last century. AD is a multifactorial disease triggered by both genetic and environmental
risk factors and twin studies indicate that the genetic contribution is substantial. Many genomewide
linkage studies mapped a number of susceptibility regions on chromosomes 1q21 (ATOD2), 3q21
(ATOD1), 5q31-q33 (ATOD6), 13q12-q14 (ATOD5), 17q25 (ATOD4), 20p (ATOD3). Three of these
loci (1q21, 17q25 and 20p) are closely coincident with psoriasis susceptibility loci, although AD is quite
distinct from psoriasis and rarely the two diseases occur together in the same patient. ProbablyAD is
in£uenced by genes that regulate the dermal responses to environmental factors independently from
atopic mechanisms. Preliminary genetic studies have identi¢ed genes or clusters of genes that are ex-
pressed in the outermost layer of the skin to be just as important as genes that may modify the atopic
process. In addition recent studies showed ¢ve overlapping chromosomal regions (1q21, 2q33, 5q31.1^
q33.1, and 6p21, 11q13) that co-localize with disease loci for the following diseases: diabetes, asthma,
atopic dermatitis, osteoporosis, and in£ammatory bowel disease (IBD). It is most likely that the same
predisposing genes are involved in di¡erent complex diseases. Finally, association studies approach
based on maps of single nucleotide polymorphisms can be lead to the identi¢cation of the genes in-
volved in pathogenesis of AD. Identi¢cation of genes or cluster of genes immediately leads to knowl-
edge of relevant proteins and any understanding of the molecular and physiological basis of disease.
The Global Initiative for Asthma (GINA) Guidelines: An Update
L.M. Fabbri
Section of Respiratory Diseases, Department of Medicine, Oncology and Radiology, University of Modena &
Reggio Emilia, Modena, Italy
Asthma is a major cause of chronic morbidity and mortality throughout the world. The Global In-
itiative for Asthma (GINA) was created to increase worldwide awareness of asthma and to make re-
commendations for prevention and management in order to encourage a concerted worldwide e¡ort.
The presentation provides an overview of the 2002 GINA recommendations and some of the scienti-
¢c evidence on which they are founded. These guidelines rede¢ne asthma, placing greater emphasis
on the key role of the underlying in£ammatory response in asthma. This de¢nition calls for new
approaches to clinical diagnosis, prevention, and management of the disorder, which are presented
here. Also described are newer clinical ¢ndings that will impact future iterations of GINA recom-
mendations.
Allergic Rhinitis Comorbities: Conjunctivitis
E. Compalati, L. Guerra, P. Massacane, F. Fumagalli, and G.W. Canonica
Allergy and Respiratory Diseases, DiMI, University of Genoa, Italy
Allergic rhinitis is an in£ammatory disorder of the nose induced by an IgE-mediated reaction following
allergen exposure of the mucous membranes lining the nose. Allergic rhinitis is still increasing in preva-
lence a¡ecting 25^35% of the population. It is characterised by rhinorrhoea, itching, sneezing and nasal
obstruction. 33^56% of patients with allergic rhinitis experience symptoms of allergic conjunctivitis. Al-
lergic rhinitis results from IgE-mediated allergy, associated with cellular in£ammation of the nasal mucosa
(eosinophilic in£ammation, enhanced expression of endothelial and epithelial adhesion molecules, cyto-
kines and chemokines). A continuous low-dose allergen exposure involves a mucosal minimal persistent
in£ammation (MPI). The clinical history and in vivo or in vitro tests for detection of speci¢c IgE con¢rm
the diagnosis of allergic rhinitis. Treatment of allergic rhinitis comprises avoidance of the allergens, oral/
nasal antihistamines, decongestants, chromones, and intranasal/oral corticosteroids. It is advised to follow ‘a
stepwise approach’. Allergic conjunctivitis is the most common ocular allergic disorder, a¡ecting 5^22% of
the population. Ocular allergy involves typical symptoms (itching, watery, stringy or ropy discharge and
redness, periorbital oedema) and recurrent/intermittent/persistent episodes. Symptoms can show variation
due to £uctuation in allergen load. Treatment of allergic conjunctivitis includes oral/eyedrop antihista-
mines, topical cromones and topical corticosteroids. A combined antihistamine and ocular mast cell stabi-
liser is more e¡ective at relieving symptoms compared with either antihistamines or chromones alone.
Oral treatment with antihistamines modi¢es both nasal and ocular symptoms and provides e¡ective con-
trol throughout a 24 h period with very high tolerability. Speci¢c immunotherapy, when indicated, plays a
role by changing the natural history of rhino-conjunctival associated disease. Topical corticosteroids are
appropriate for short-term use in severe conditions only. All this matter has been recently summarized in
the ARIA-WAO-WHO document. New medications against other in£ammatory mediators may be the
next signi¢cant advance in this model of treatment. Partially supported byA.R.M.I.A.
Double-Blind Placebo Controlled (DBPCFC) Cake Challenges for Hidden Egg in
Older Children with Atopic Eczema
L. Morton, P.Waugh, and R. Lever
Depts of Dermatology & Dietetics Royal Hospital for Sick Children, Glasgow, UK
Food allergy can be a signi¢cant problem in young children (o2years) with atopic eczema (AE). (1)
Although allergy to peanuts and ¢sh tend to be lifelong, tolerance to other allergens such as milk and
eggs usually develops within the ¢rst ¢ve years of life. Only a minority of the older children has persis-
tent problems to these allergens. In the younger child, the speci¢c IgE level to eggs can be a useful guide
to the predictor of sensitivity. (2) In addition, some of the egg allergic children can tolerate hidden eggs,
for example in cakes & sweets, although react to eggs ‘as is’. This study aimed to: 1) challenge (DBPCFC)
older egg allergic children with AE to ‘hidden’egg 2) examine whether the speci¢c IgE level is a useful
predictor of outcome. Twenty ¢ve children (14 girls: 11 boys) aged 6^13 years (mean 8.9972.25) were
included in the study. All were allergic to eggs having had a previous positive DBPCFC to eggs. The
total speci¢c IgE ranged from 0^45000 ku/l (mean 706.37637.6) with a speci¢c IgE to egg from 0^
41.7 ku/l (mean 6.0478.77). All attended the Day Unit for the challenge, where resuscitation facilities
are available. Two cakes (one egg free) were tested: children were given incremental amounts of one in
the morning and the other one in the afternoon. 18/25 (72%) of the challenges were negative allowing
unnecessary dietary restrictions to be lifted. Of the seven positive challenges: 3 were purely cutaneous
(urticaria & facial erythema). One was gastro-intestinal with abdominal pain & nausea. Two were more
signi¢cant, with only tiny amounts of cake leading to respiratory problems in one child (which settled
spontaneously) and to pallor and a choking sensation in the second, that settled with oral chlorphenira-
mine. In contrast to younger children, neither the total nor speci¢c IgE levels were helpful in determin-
ing outcome.The mean total IgE was 592 ku/l (7575) v 718 (7820) with a speci¢c IgE to egg of 6.0 ku/l
(79.6) v 5.0 (77.1) in the tolerant group & sensitive group respectively. Dietary restrictions become more
irksome as children grow older and it is important that unnecessary dietary restrictions are lifted. How-
ever, some children remain sensitive to eggs and it is useful to establish safely whether this applies to all
egg products or whether ‘hidden egg’can be tolerated.
1) Lever R, 2001 The role of food in atopic eczema J Am Acad Dermatol 45 S57-60 Morton J,
Waugh P, Lever R Double-blind food challenges in children with atopic eczema Poster Presentation
Scottish NHS Conference 2000
Antinuclear Antibodies in Patients with Atopic Dermatitis
N. Higashi, and S. Kawana
Department of Dermatology, Nippon Medical School,Tokyo, Japan
Background: So far several autoantibodies have detected in the patients with atopic dermatitis (AD).
Twenty to thirty percentages of AD patients showed positive antinuclear antibodies (ANA). However,
the role of autoantibody in the pathogenesis of AD has not yet been fully elucidated. Recently we
have treated with AD complicated with systemic lupus erythematosus (SLE).
Objective: The aim was to re-elucidate the prevalence of ANA in patients with AD and the di¡erence
between ANA(þ ) and ANA() patients with AD.
Methods: Disease severity, photosensitivity, ANA, blood eosinophil count, total IgE levels, speci¢c IgE
antibodies to enviromental antigens were checked in 64 patients with AD. The relationship between
ANA(þ ) and ANA () patients with AD were statistically evaluated.
Results & Conclusion: Eighteen of 64 (28.1%) AD showed positive ANA at titers ranging from 20X to
640X. Eight of 37 (21.6%) and 10 of 27 (37%) AD with ANA(þ ) were male and female respectively.
Positive ANA had relevance to photosensitivity and severe facial lesions in patients with AD.
Atopic Dermatitis Complicated with Systemic Lupus Erythematosus
N. Higashi, and S. Kawana
Department of Dermatology, Nippon Medical School,Tokyo, Japan
The relationship between allergic and autoimmune disease remains to be uncovered. So far there are a
few case reports of atopic dermatitis (AD) complicated with systemic lupus erythematosus (SLE).
Case1: A 25-years-old male, who had su¡ered AD since 5 years of age, was admitted to our hospital
complaining of butter£y erythema. Laboratory test gave the following results: leukopenia, antinuclear
antibody (ANA)(no20X), 640Xo (Sp); anti-ssDNA (no25), 36.9 AU/ml; anti-RNP (no10), 500o
U/ml; anti-SSA (no10), 27.4 U/ml; CH50 (n¼ 32^44), 10.7 IU/ml; C3 (n¼ 80^150), 51 mg/dl; C4
(n¼15^40), 7 mg/dl, IgE (no250) 9400 IU/ml and proteinuria (0.3 g/day). Membranous nephropathy
stage III was diagnosed. Case2: A 27-years-old male, who had su¡ered mild AD since childhood, was
admitted complaining of facial edema. Laboratory test gave the following results: leukopenia, hypoal-
buminemia, liver distrubance, renal disorder, ANA 320Xo (Hoþ SpþNu); anti-ssDNA, 37.5 AU/
ml; anti-dsDNA (no12), 137.2 IU/ml; anti-SSA, 86.2 U/ml; CH50, o6.3 IU/ml; C3, 28 mg/dl; C4, 3
mg/dl; IgE, 140 IU/ml and proteinuria (4.1 g/day). Lupus nephritis IV b was diagnosed. Histopatholgi-
cal ¢ndings of skin showed slight liquefaction degeneration of the basal layer, and lupus band test was
positive in both cases. Discussion: In our department, three patients who had su¡ered from AD (15%)
in 20 of SLE patients. It is well known that enhanced Th2 cytokine pro¢le is observed in AD and
SLE. It seems that some part of common immune dysfunction underlie in etiology of AD and SLE.
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